Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Dr. med. Stefan Kasper

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Certa, Franziska; Horn, Peter; Keyl, Julius; Mende, Bastian; Lueong, Smiths; Hilser, Thomas; Theurer, Sarah; Virchow, Isabel; Zaun, Yasmin; Pogorzelski, Michael; Metzenmacher, Martin; Kalkavan, Halime; Kasper, Stefan; Schuler, Martin; Wiesweg, Marcel; Zaun, Gregor
    ABO‐Blood Group Associates With Survival Outcomes in Patients With Metastatic Non‐Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy
    In: Thoracic Cancer , Jg. 16 2025, Nr. 6, e70037
    DOI (Open Access)
  • Keyl, Julius; Keyl, Philipp; Montavon, Grégoire; Hosch, René; Brehmer, Alexander; Mochmann, Liliana; Jurmeister, Philipp; Dernbach, Gabriel; Kim, Moon; Koitka, Sven; Bauer, Sebastian; Bechrakis, Nikolaos; Forsting, Michael; Führer-Sakel, Dagmar; Glas, Martin; Grünwald, Viktor; Hadaschik, Boris; Haubold, Johannes; Herrmann, Ken; Kasper, Stefan; Kimmig, Rainer; Lang, Stephan; Rassaf, Tienush; Roesch, Alexander; Schadendorf, Dirk; Siveke, Jens T.; Stuschke, Martin; Sure, Ulrich; Totzeck, Matthias; Welt, Anja; Wiesweg, Marcel; Baba, Hideo A.; Nensa, Felix; Egger, Jan; Müller, Klaus-Robert; Schuler, Martin; Klauschen, Frederick; Kleesiek, Jens
    Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence
    In: Nature Cancer , Jg. 6 2025, Nr. 2, S. 307 – 322
    DOI (Open Access)
  • Köhler, Franziska; Arnold, Dirk; Aust, Daniela; Betge, Johannes; Brecht, Ines B.; Germer, Christoph-Thomas; Grouven, Bernd; Harter, Philipp; Kasper-Virchow, Stefan; Koslowski, Kai; Neeff, Hannes Philipp; Neumann, Jens; Piso, Pompiliu; Rau, Beate; Schneider, Dominik T.; Schreyer, Andreas G.; Kröplin, Maria A.; Wiegering, Armin
    German S2k-guideline on diagnostics, treatment and surveillance of low-grade appendiceal mucinous neoplasms (LAMN)
    In: European Journal of Cancer (EJC) , Jg. 222 2025, 115430
    DOI (Open Access)
  • Watanabe, Masao; Fendler, Wolfgang; Grafe, Hong; Hirmas, Nader; Hamacher, Rainer; Lanzafame, Helena; Pabst, Kim M.; Hautzel, Hubertus; Aigner, Clemens; Kasper, Stefan; von Tresckow, Bastian; Stuschke, Martin; Kümmel, Sherko; Lugnier, Celine; Hadaschik, Boris; Grünwald, Viktor; Zarrad, Fadi; Kersting, David; Siveke, Jens T.; Herrmann, Ken; Weber, Manuel
    Head-to-head comparison of ⁶⁸ Ga-FAPI-46 PET/CT, ¹⁸F-FDG PET/CT, and contrast-enhanced CT for the detection of various tumors
    In: Annals of Nuclear Medicine , Jg. 39 2025, Nr. 3, S. 255 – 265
    DOI
  • Stahler, Arndt; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Müller, Lothar; Fischer von Weikersthal, Ludwig; Caca, Karel; Goekkurt, Eray; Ballhausen, Alexej; Sommerhäuser, Greta; Alig, Annabel H.S.; Held, Swantje; Jarosch, Armin; Horst, David; Reinacher-Schick, Anke; Kasper, Stefan; Heinemann, Volker; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik P.
    Panitumumab plus 5-fluorouracil and folinic acid or 5-fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212) : final efficacy analysis of a randomised, open-label, phase 2 trial
    In: eClinicalMedicine , Jg. 79 2025, 103004
    DOI (Open Access)
  • Kasper, Stefan; Sebastian, Martin
    Pharmakologische Hemmung von KRAS -Mutanten bei Krebserkrankungen : Therapieprinzip und klinische Ergebnisse
    In: Deutsches Ärzteblatt international , Jg. 122 2025, Nr. 6, S. 163 – 167
    DOI
  • Stintzing, S.; Tabernero, J.; Satoh, T.; Dasari, A.; Lonardi, S.; Eng, C.; Garcia-Carbonero, R.; Elez, E.; Yoshino, T.; Sobrero, A.F.; Yao, J.C.; Kasper, Stefan; Arnold, D.; Basic, E.; Granold, M.; Petschulies, M.; Wu, L.; Chung, Y.-C.; Chen, L.; Yang, Z.; Van Cutsem, E.
    Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib plus best supportive care : results from FRESCO-2
    In: ESMO Open , Jg. 10 2025, Nr. 3, 104297
    DOI (Open Access)
  • Kasper, Stefan; Liszio, S.; Schorrmann, Katrin; Gerigk, Monja; Jovic, Slobodan; Basu, Oliver; Kostbade, Karina; Goraus, Beate; Elsakka, Abdelrahman; Puladi, B.; Kleesiek, Jens; Schuler, Martin; Luijten, G.; Egger, Jan
    Virtual reality support during systemic cancer therapy to improve anxiety/depressive symptoms and reduce toxicity in patients with gastrointestinal cancers—OncoVR
    In: ESMO Gastrointestinal Oncology , Jg. 7 2025, 100135
    DOI (Open Access)
  • Pfeifer, Klara; Tewes, Mitra; Kasper, Stefan; Hense, Jörg; Franco, Jan; Schuler, Martin; Schöbel, Christoph; Ates, Gülay
    Applicability of a digital health application for cancer patients : A qualitative non-participation analysis
    In: BMC Health Services Research , Jg. 24 2024, Nr. 1, 1187
    DOI (Open Access)
  • Bokemeyer, Carsten; Ciardiello, Fortunato; Dubreuil, Olivier; Guigay, Joel; Kasper, Stefan; Pfeiffer, Per; Pinto, Carmine; Yamaguchi, Kensei; Yoshino, Takayuki; Zielinski, Christoph; Esser, Regina; Tabernero, Josep
    Cetuximab Every 2 Weeks Versus Standard Weekly Dosing Administration Schedule
    In: Future Oncology , Jg. 20 2024, Nr. 7, S. 393 – 407
    DOI (Open Access)
  • Zaun, Gregor; Borchert, Sabrina; Metzenmacher, Martin; Lueong, Smiths; Wiesweg, Marcel; Zaun, Yasmin; Pogorzelski, Michael; Behrens, Franziska; Schildhaus, Hans-Ulrich; Virchow, Isabel; Kasper, Stefan; Schuler, Martin; Theurer, Sarah; Liffers, Sven
    Comprehensive biomarker diagnostics of unfavorable cancer of unknown primary to identify patients eligible for precision medical therapies
    In: European Journal of Cancer (EJC) , Jg. 200 2024, 113540
    DOI (Open Access)
  • Zensen, Sebastian; Bücker, Arno; Meetschen, Mathias; Haubold, Johannes; Opitz, Marcel; Theysohn, Jens; Schramm, Sara; Jochheim, Leonie; Kasper, Stefan; Forsting, Michael; Schaarschmidt, Benedikt Michael
    Current use of percutaneous image-guided tumor ablation for the therapy of liver tumors : Lessons learned from the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) 2018–2022
    In: European Radiology , Jg. 34 2024, Nr. 5, S. 3322 – 3330
    DOI (Open Access)
  • Ballhausen, A.; Karthaus, M.; Fruehauf, S.; Graeven, U.; Müller, L.; König, A.O.; von Weikersthal, L.F.; Sommerhäuser, G.; Jelas, I.; Alig, A.H.S.; Kurreck, A.; Stahler, A.; Goekkurt, E.; Held, S.; Kasper, Stefan; Heinrich, K.; Heinemann, V.; Stintzing, S.; Trarbach, Tanja; Modest, D.P.
    Dermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction : A prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trial
    In: ESMO Open , Jg. 9 2024, Nr. 7, 103628
    DOI (Open Access)
  • Hirmas, Nader; Hamacher, Rainer; Sraieb, Miriam; Kessler, Lukas; Pabst, Kim M.; Barbato, Francesco; Lanzafame, Helena; Kasper, Stefan; Nader, Michael; Kesch, Claudia; von Tresckow, Bastian; Hautzel, Hubertus; Aigner, Clemens; Glas, Martin; Stuschke, Martin; Kümmel, Sherko; Harter, Philipp; Lugnier, Celine; Uhl, Waldemar; Hadaschik, Boris; Grünwald, Viktor; Siveke, Jens T.; Herrmann, Ken; Fendler, Wolfgang
    Diagnostic Accuracy of ⁶⁸Ga-FAPI Versus ¹⁸F-FDG PET in Patients with Various Malignancies
    In: Journal of Nuclear Medicine (JNM) , Jg. 65 2024, Nr. 3, S. 372 – 378
    DOI (Open Access)
  • Reimann, Patrick; Mavroeidi, Ilektra-Antonia; Burghofer, Jonathan; Taghizadeh, Hossein; Webersinke, Gerald; Kasper, Stefan; Schreil, Georg; Morariu, Darius; Reichinger, Andreas; Baba, Hideo Andreas; Kirchweger, Patrick; Schuler, Martin; Djanani, Angela; Prager, Gerald W.; Rumpold, Holger; Benda, Magdalena; Schneider, Eva-Maria; Mink, Sylvia; Winder, Thomas; Doleschal, Bernhard
    Exploring the impact of durvalumab on biliary tract cancer : insights from real-world clinical data
    In: Cancer Immunology, Immunotherapy , Jg. 73 2024, Nr. 12, S. 251
    DOI (Open Access)
  • Stahler, Arndt; Kind, Andreas J.; Sers, Christine; Mamlouk, Soulafa; Müller, Lothar; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Fischer von Weikersthal, Ludwig; Sommerhäuser, Greta; Kasper, Stefan; Hoppe, Beeke; Kurreck, Annika; Held, Swantje; Heinemann, Volker; Horst, David; Jarosch, Armin; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik P.
    Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa Phase II Trial, AIO KRK 0212)
    In: Clinical Cancer Research , Jg. 30 2024, Nr. 7, S. 1256 – 1263
    DOI
  • De Lazzari, Nico; Götte, Miriam; Kasper, Stefan; Meier, Eileen; Schuler, Martin; Pogorzelski, Michael; Siveke, Jens T.; Tewes, Mitra
    P-move : A randomized control trial of exercise in patients with advanced pancreatic or biliary tract cancer (aPBC) receiving beyond first-line chemotherapy
    In: Supportive Care in Cancer , Jg. 32 2024, Nr. 7, 437
    DOI (Open Access)
  • Abu Sabbah, Tanja; Theurer, Sarah; Baba, Hideo Andreas; Lueong, Smiths; Rashidi Alavijeh, Jassin; Hilser, Thomas; Zaun, Yasmin; Metzenmacher, Martin; Pogorzelski, Michael; Virchow, Isabel; Pretzell, Ina; Kostbade, Karina; Treckmann, Jürgen; Wiesweg, Marcel; Schuler, Martin; Kasper, Stefan; Zaun, Gregor
    PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors
    In: European Journal of Cancer (EJC) , Jg. 210 2024, 114268
    DOI (Open Access)
  • Watanabe, Masao; Fendler, Wolfgang; Grafe, Hong; Hirmas, Nader; Hamacher, Rainer; Lanzafame, Helena; Pabst, Kim M.; Hautzel, Hubertus; Aigner, Clemens; Kasper, Stefan; von Tresckow, Bastian; Stuschke, Martin; Kümmel, Sherko; Lugnier, Celine; Hadaschik, Boris; Grünwald, Viktor; Zarrad, Fadi; Siveke, Jens T.; Herrmann, Ken; Weber, Manuel
    Prognostic Implications of ⁶⁸Ga-FAPI-46 PET/CT-Derived Parameters on Overall Survival in Various Types of Solid Tumors
    In: Journal of Nuclear Medicine (JNM) , Jg. 65 2024, Nr. 7, S. 1027 – 1034
    DOI
  • Sommerhäuser, Greta; Karthaus, Meinolf; Kurreck, Annika; Ballhausen, Alexej; Meyer-Knees, Johanna W.; Fruehauf, Stefan; Graeven, Ullrich; Mueller, Lothar; Koenig, Alexander O.; Fischer V. Weikersthal, Ludwig; Goekkurt, Eray; Haas, Siegfried; Stahler, Arndt; Heinemann, Volker; Held, Swantje; Alig, Annabel H. S.; Kasper-Virchow, Stefan; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik P.
    Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer : Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212)
    In: International Journal of Cancer , Jg. 154 2024, Nr. 5, S. 863 – 872
    DOI (Open Access)
  • Keyl, Julius; Bucher, A.; Jungmann, F.; Hosch, R.; Ziller, A.; Armbruster, R.; Malkomes, P.; Reissig, T.M.; Koitka, S.; Tzianopoulos, I.; Keyl, P.; Kostbade, K.; Albers, David; Markus, P.; Treckmann, Jürgen-Walter; Naßenstein, Kai; Haubold, Johannes; Makowski, M.; Forsting, Michael; Baba, Hideo Andreas; Kasper, Stefan; Siveke, Jens T.; Nensa, Felix; Schuler, Martin; Kaissis, G.; Kleesiek, Jens; Braren, R.
    Prognostic value of deep learning-derived body composition in advanced pancreatic cancer : A retrospective multicenter study
    In: ESMO Open , Jg. 9 2024, Nr. 1, 102219
    DOI, Online Volltext (Open Access)
  • Mavroeidi, Ilektra Antonia; Burghofer, Jonathan; Kalbourtzis, Stavros; Taghizadeh, Hossein; Webersinke, Gerald; Piringer, Gudrun; Kasper, Stefan; Schreil, Georg; Liffers, Sven Thorsten; Reichinger, Andreas; Kirchweger, P.; Heibl, Sonja; Hamacher, Rainer; Schmitt, Clemens A.; Schuler, Martin; Prager, Gerald W.; Kersting, David; Treckmann, Jürgen-Walter; Schildhaus, Hans-Ulrich; Rumpold, Holger F.; Siveke, Jens T.; Doleschal, Bernhard
    Understanding homologous recombination repair deficiency in biliary tract cancers : clinical implications and correlation with platinum sensitivity
    In: ESMO Open , Jg. 9 2024, Nr. 8, 103630
    DOI (Open Access)
  • Virchow, Isabel; Treckmann, Jürgen-Walter; Prasnikar, Nicole; Linden, Gabriele; Markus, Peter; Schumacher, Brigitte; Albers, David; Herold, Thomas; Ting, Saskia; Schmidt, Hartmut; Radunz, Sonja; Wiesweg, Marcel; Siveke, Jens; Schuler, Martin; Kasper, Stefan
    A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO)
    In: Oncology Research and Treatment , Jg. 46 2023, Nr. 3, S. 89 – 99
    DOI
  • Maßmann, M.; Treckmann, Jürgen Walter; Markus, P.; Schumacher, B.; Albers, D.; Ting, Saskia; Mende, B.; Roehrle, J.; Virchow, I.; Rosery, V.; Laue, K.; Zaun, G.; Kostbade, K.; Pogorzelski, M.; Schmid, Kurt Werner; Baba, Hideo Andreas; Siveke, Jens T.; Paul, A.; Schildhaus, Hans-Ulrich; Schuler, Martin; Wiesweg, Marcel; Kasper, Stefan
    A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma
    In: Journal of Cancer Research and Clinical Oncology , Jg. 149 2023, Nr. 8, S. 5085 – 5094
    DOI (Open Access)
  • Roehrle, Julius; Kasper, Stefan; Treckmann, Jürgen-Walter; Markus, Peter; Schumacher, Brigitte; Albers, David; Wendling, Johanna; Ting, Saskia; Mende, Bastian; Maßmann, Marlene; Markus, Maximilian; Virchow, Isabel; Rosery, Vivian; Laue, Katharina; Zaun, Gregor; Kostbade, Karina; Pogorzelski, Michael; Reissig, Timm M.; Liffers, Sven-Thorsten; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Schuler, Martin; Siveke, Jens; Wiesweg, Marcel
    Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy Protocols
    In: Oncology Research and Treatment , Jg. 46 2023, Nr. 4, S. 140 – 150
    DOI
  • Meric-Bernstam, Funda; Sweis, Randy F.; Kasper, Stefan; Hamid, Omid; Bhatia, Shailender; Dummer, Reinhard; Stradella, Agostina; Long, Georgina V.; Spreafico, Anna; Shimizu, Toshio; Steeghs, Neeltje; Luke, Jason J.; McWhirter, Sarah M.; Müller, Thomas; Nair, Nitya; Lewis, Nancy; Chen, Xinhui; Bean, Andrew; Kattenhorn, Lisa; Pelletier, Marc; Sandhu, Shahneen
    Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas : An Open-Label, Multicenter, Phase Ib Study
    In: Clinical Cancer Research , Jg. 29 2023, Nr. 1, S. 110 – 121
    DOI (Open Access)
  • Stahler, Arndt; Hoppe, Beeke; Na, Il-Kang; Keilholz, Luisa; Müller, Lothar; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Fischer Von Weikersthal, Ludwig; Goekkurt, Eray; Kasper, Stefan; Kind, Andreas Jay; Kurreck, Annika; Alig, Annabel Helga Sophie; Held, Swantje; Reinacher-Schick, Anke; Heinemann, Volker; Horst, David; Jarosch, Armin; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik Paul
    Consensus Molecular Subtypes as Biomarkers of Fluorouracil and Folinic Acid Maintenance Therapy With or Without Panitumumab in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212)
    In: Journal of Clinical Oncology (JCO) , Jg. 41 2023, Nr. 16, S. 2975 – 2987
    DOI
  • Keyl, Julius; Hosch, René; Berger, Aaron; Ester, Oliver; Greiner, Tobias; Bogner, Simon; Treckmann, Jürgen; Ting, Saskia; Schumacher, Brigitte; Albers, David; Markus, Peter; Wiesweg, Marcel; Forsting, Michael; Nensa, Felix; Schuler, Martin; Kasper, Stefan; Kleesiek, Jens
    Deep learning-based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer
    In: Journal of Cachexia, Sarcopenia and Muscle , Jg. 14 2023, Nr. 1, S. 545 – 552
    DOI, Online Volltext (Open Access)
  • Sommerhäuser, Greta; Kurreck, Annika; Beck, Alexander; Fehrenbach, Uli; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Mueller, Lothar; Koenig, Alexander O.; v. Weikersthal, Ludwig F.; Goekkurt, Eray; Haas, Siegfried; Stahler, Arndt; Heinemann, Volker; Held, Swantje; Alig, Annabel H.S.; Kasper, Stefan; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik P.
    Depth of response of induction therapy and consecutive maintenance treatment in patients with RAS wild-type metastatic colorectal cancer : An analysis of the PanaMa trial (AIO KRK 0212)
    In: European Journal of Cancer (EJC) , Jg. 178 2023, S. 37 – 48
    DOI
  • Psyrri, Amanda; Fayette, J.; Harrington, K.; Gillison, M.; Ahn, M.-J.; Takahashi, S.; Weiss, J.; Machiels, J.-P.; Baxi, S.; Vasilyev, A.; Karpenko, A.; Dvorkin, M.; Hsieh, C.-Y.; Thungappa, S.C.; Segura, P.P.; Vynnychenko, I.; Haddad, R.; Kasper, Stefan; Mauz, P.-S.; Baker, V.; He, P.; Evans, B.; Wildsmith, S.; Olsson, R.F.; Yovine, A.; Kurland, J.F.; Morsli, N.; Seiwert, Tanguy Y.
    Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck : KESTREL, a randomized, open-label, phase III study
    In: Annals of Oncology , Jg. 34 2023, Nr. 3, S. 262 – 274
    DOI (Open Access)
  • Stintzing, Sebastian; Heinrich, Kathrin; Tougeron, David; Modest, Dominik Paul; Schwaner, Ingo; Eucker, Jan; Pihusch, Rudolf; Stauch, Martina; Kaiser, Florian; Kahl, Christoph; Karthaus, Meinolf; Müller, Christian; Burkart, Christof; Reinacher-Schick, Anke; Kasper-Virchow, Stefan; Fischer von Weikersthal, Ludwig; Krammer-Steiner, Beate; Prager, Gerald Wolfgang; Taieb, Julien; Heinemann, Volker
    FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAF V⁶⁰⁰E-Mutant Metastatic Colorectal Cancer : The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study
    In: Journal of Clinical Oncology (JCO) , Jg. 41 2023, Nr. 25, S. 4143 – 4153
    DOI (Open Access)
  • Kraskowski, Oliver; Stratmann, Jan A.; Wiesweg, Marcel; Eberhardt, Wilfried; Metzenmacher, Martin; Schmid, Kurt Werner; Herold, Thomas; Schildhaus, Hans-Ulrich; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Laue, Katharina; Zaun, Gregor; Kasper, Stefan; Hense, Jörg; Sebastian, Martin; Schuler, Martin; Pogorzelski, Michael
    Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting
    In: Journal of Cancer Research and Clinical Oncology , Jg. 149 2023, Nr. 11, S. 9243 – 9252
    DOI (Open Access)
  • Hirmas, Nader; Hamacher, Rainer; Sraieb, Miriam; Ingenwerth, Marc; Kessler, Lukas; Pabst, Kim M.; Barbato, Francesco; Lückerath, Katharina; Kasper, Stefan; Nader, Michael; Schildhaus, Hans-Ulrich; Kesch, Claudia; von Tresckow, Bastian; Hanoun, Christine; Hautzel, Hubertus; Aigner, Clemens; Glas, Martin; Stuschke, Martin; Kümmel, Sherko; Harter, Philipp; Lugnier, Celine; Uhl, Waldemar; Niedergethmann, Marco; Hadaschik, Boris; Grünwald, Viktor; Siveke, Jens; Herrmann, Ken; Fendler, Wolfgang
    Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
    In: Journal of Nuclear Medicine (JNM) , Jg. 64 2023, Nr. 5, S. 711 – 716
    DOI (Open Access)
  • Dasari, Arvind; Lonardi, Sara; Garcia-Carbonero, Rocio; Elez, Elena; Yoshino, Takayuki; Sobrero, Alberto; Yao, James; García-Alfonso, Pilar; Kocsis, Judit; Cubillo Gracian, Antonio; Sartore-Bianchi, Andrea; Satoh, Taroh; Randrian, Violaine; Tomasek, Jiri; Chong, Geoff; Paulson, Andrew Scott; Masuishi, Toshiki; Jones, Jeremy; Csőszi, Tibor; Cremolini, Chiara; Ghiringhelli, Francois; Shergill, Ardaman; Hochster, Howard S; Krauss, John; Bassam, Ali; Ducreux, Michel; Elme, Anneli; Faugeras, Laurence; Kasper, Stefan; Van Cutsem, Eric; Arnold, Dirk; Nanda, Shivani; Yang, Zhao; Schelman, William R; Kania, Marek; Tabernero, Josep; Eng, Cathy
    Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2) : an international, multicentre, randomised, double-blind, phase 3 study
    In: Lancet , Jg. 402 2023, Nr. 10395, S. 41 – 53
    DOI
  • Ballhausen, Alexej; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Müller, Lothar; König, Alexander Otto; Fischer von Weikersthal, Ludwig; Sommerhäuser, Greta; Alig, Annabel Helga Sophie; Goekkurt, Eray; Meyer-Knees, Johanna Wanda; Kurreck, Annika; Stahler, Arndt; Held, Swantje; Kasper, Stefan; Heinrich, Kathrin; Heinemann, Volker; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik Paul
    Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy : A prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial
    In: European Journal of Cancer (EJC) , Jg. 190 2023, 112955
    DOI
  • Rosery, Vivian; Mika, Stephan; Schmid, Kurt Werner; Reis, Henning; Stuschke, Martin; Treckmann, Jürgen; Markus, Peter; Schumacher, Brigitte; Albers, David; Mende, Bastian; Lahner, Harald; Wiesweg, Marcel; Schuler, Martin; Siveke, Jens T.; Kasper, Stefan
    Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy
    In: Journal of Cancer Research and Clinical Oncology , Jg. 149 2023, Nr. 8, S. 4315 – 4325
    DOI (Open Access)
  • Zurloh, M.; Goetz, M.; Herold, T.; Treckmann, Jürgen-Walter; Markus, P.; Schumacher, B.; Albers, D.; Rink, A.; Rosery, V.; Zaun, G.; Kostbade, K.; Pogorzelski, M.; Ting, S.; Schmidt, H.; Stiens, R.; Wiesweg, Marcel; Schuler, Martin; Kasper, Stefan; Virchow, I.
    Impact of encorafenib on survival of patients with BRAFV⁶⁰⁰E-mutant metastatic colorectal cancer in a real-world setting
    In: Journal of Cancer Research and Clinical Oncology , Jg. 149 2023, Nr. 14, S. 12903 – 12912
    DOI (Open Access)
  • Grapatsas, Konstantinos; Dörr, Fabian; Menghesha, Hruy; Schuler, Martin; Grünwald, Viktor; Bauer, Sebastian; Schmidt, Hartmut H. -J.; Lang, Stephan; Kimmig, Rainer; Kasper, Stefan; Baldes, Natalie; Bölükbas, Servet
    New Prognostic Score (Essen Score) to Predict Postoperative Morbidity after Resection of Lung Metastases
    In: Cancers , Jg. 15 2023, Nr. 17, 4355
    DOI, Online Volltext (Open Access)
  • Kasper, Stefan; Foch, Caroline; Esser, Regina; Lamy, Francois-Xavier; Zhang, Aimar; Cheng, Ann-Lii; Rouyer, Magali; Brodowicz, Thomas; Zielinski, Christoph
    Overall survival with cetuximab every-2-weeks versus standard once-weekly administration schedule for first-line treatment of RAS wild-type metastatic colorectal cancer in patients with left- and right-sided primary tumour location
    In: European Journal of Cancer (EJC) , Jg. 180 2023, S. 85 – 88
    DOI
  • Civan, Caner; Kasper, Stefan; Berliner, Christoph; Fragoso-Costa, Pedro; Grünwald, Viktor; Pogorzelski, Michael; Schaarschmidt, Benedikt Michael; Lang, Stephan; Kersting, David; Nader, Michael; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang P.; Weber, Manuel
    PSMA-Directed Imaging and Therapy of Salivary Gland Tumors : A Single-Center Retrospective Study
    In: Journal of Nuclear Medicine (JNM) , Jg. 64 2023, Nr. 3, S. 372 – 378
    DOI (Open Access)
  • Van Cutsem, Eric; Yaeger, Rona; Delord, Jean-Pierre; Tabernero, Josep; Siu, Lillian L; Ducreux, Michel; Siena, Salvatore; Elez, Elena; Kasper, Stefan; Zander, Thomas; Steeghs, Neeltje; Murphy, Danielle; Edwards, Michelle; Wainberg, Zev A
    Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer
    In: The Oncologist , Jg. 28 2023, Nr. 12, S. e1209 – e1218
    DOI (Open Access)
  • Schaarschmidt, Benedikt M.; Kloeckner, Roman; Dertnig, Thomas; Demircioglu, Aydin; Müller, Lukas; Auer, Timo Alexander; Santos, Daniel Pinto Dos; Steinle, Verena; Miederer, Matthias; Gebauer, Bernhard; Radunz, Sonia; Kasper, Stefan; Weber, Manuel; Theysohn, Jens
    Real-Life Experience in the Treatment of Intrahepatic Cholangiocarcinoma by ⁹⁰Y Radioembolization : A Multicenter Retrospective Study
    In: Journal of Nuclear Medicine (JNM) , Jg. 64 2023, Nr. 4, S. 529 – 535
    DOI (Open Access)
  • Zaun, Gregor; Weber, Manuel; Metzenmacher, Martin; Wiesweg, Marcel; Hilser, Thomas; Zaun, Yasmin; Liffers, Sven; Pogorzelski, Michael; Virchow, Isabel; Eberhardt, Wilfried; Theurer, Sarah; Sabbah, Tanja Abu; Reissig, Timm M.; Stuschke, Martin; Kürten, Cornelius; Hussain, Timon; Lang, Stephan; Kasper, Stefan; Fendler, Wolfgang; Herrmann, Ken; Schuler, Martin
    SUVmₐₓ Above 20 in ¹⁸F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown Primary
    In: Journal of Nuclear Medicine (JNM) , Jg. 64 2023, Nr. 8, S. 1191 – 1194
    DOI (Open Access)
  • Reissig, T.M.; Tzianopoulos, I.; Liffers, S.-T.; Rosery, V.K.; Guyot, M.; Ting, S.; Wiesweg, Marcel; Kasper, S.; Meister, P.; Herold, T.; Schmidt, H.H.; Schumacher, B.; Albers, David; Markus, P.; Treckmann, J.; Schuler, Martin; Schildhaus, Hans-Ulrich; Siveke, Jens
    Smaller panel, similar results : Genomic profiling and molecularly informed therapy in pancreatic cancer
    In: ESMO Open , Jg. 8 2023, Nr. 3, 101539
    DOI (Open Access)
  • Pabst, Kim M.; Trajkovic-Arsic, Marija; Cheung, Phyllis F Y; Ballke, Simone; Steiger, Katja; Bartel, Timo; Schaarschmidt, Benedikt M.; Milosevic, Aleksandar; Seifert, Robert; Nader, Michael; Kessler, Lukas; Siveke, Jens T.; Lückerath, Katharina; Kasper, Stefan; Herrmann, Ken; Hirmas, Nader; Schmidt, Hartmut; Hamacher, Rainer; Fendler, Wolfgang
    Superior Tumor Detection for ⁶⁸Ga-FAPI-46 Versus ¹⁸F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma
    In: Journal of Nuclear Medicine (JNM) , Jg. 64 2023, Nr. 7, S. 1049 – 1055
    DOI (Open Access)
  • Hofheinz, Ralf; Arnold, Dirk; Fichtner-Feigl, Stefan; Fokas, Emmanouil; Folprecht, Gunnar; Geissler, Michael; Ghadimi, Michael; Hegewisch-Becker, Susanne; Heinemann, Volker; Kasper-Virchow, Stefan; Kubicka, Stefan; Modest, Dominik Paul; Piso, Pompilio; Reinacher-Schick, Anke; Rödel, Claus-Michael; Seufferlein, Thomas; Stein, Alexander; Stintzing, Sebastian
    Arbeitsgruppen zu kolorektalen Tumoren der AIO, der ACO und der ARO – „past, present, and future“
    In: Der Onkologe , Jg. 28 2022, Nr. Suppl. 1, S. 44 – 49
    DOI
  • Modest, Dominik Paul; Karthaus, Meinolf; Kasper, Stefan; Moosmann, Nicolas; Keitel, Verena; Kiani, Alexander; Uhlig, Jens; Jacobasch, Lutz; Fischer v. Weikersthal, Ludwig; Fuchs, Martin; Kaiser, Florian; Lerchenmüller, Christian; Sent, Dagmar; Junghanß, Christian; Held, Swantje; Lorenzen, Sylvie; Kaczirek, Klaus; Jung, Andreas; Stintzing, Sebastian; Heinemann, Volker
    FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases : The PARLIM trial (AIO KRK 0314)
    In: European Journal of Cancer (EJC) , Jg. 173 2022, S. 297 – 306
    DOI
  • Rink, Andreas D.; Kasper, Stefan
    Heilung ohne Operation und Radiochemotherapie beim lokal fortgeschrittenen, Mismatch-Reparatur-defizienten Rektumkarzinom?
    In: Coloproctology , Jg. 44 2022, Nr. 5, S. 357 – 360
    DOI
  • Gillison, Maura L.; Blumenschein, George; Fayette, Jerome; Guigay, Joel; Colevas, A. Dimitrios; Licitra, Lisa; Harrington, Kevin J.; Kasper, Stefan; Vokes, Everett E.; Even, Caroline; Worden, Francis; Saba, Nabil F.; Iglesias Docampo, Lara Carmen; Haddad, Robert; Rordorf, Tamara; Kiyota, Naomi; Tahara, Makoto; Jayaprakash, Vijayvel; Wei, Li; Ferris, Robert L
    Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer : Subgroup Analysis of CheckMate 141
    In: The Oncologist , Jg. 27 2022, Nr. 2, S. e194 – e198
    DOI (Open Access)
  • Keyl, J.; Kasper, S.; Wiesweg, Marcel; Götze, J.; Schönrock, M.; Sinn, M.; Berger, A.; Nasca, E.; Kostbade, K.; Schumacher, B.; Markus, P.; Treckmann, Jürgen-Walter; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Siveke, Jens; Schuler, Martin; Kleesiek, J.
    Multimodal survival prediction in advanced pancreatic cancer using machine learning
    In: ESMO Open , Jg. 7 2022, Nr. 5, 100555
    DOI, Online Volltext (Open Access)
  • Kasper-Virchow, Stefan; Nitschmann, Sirka
    Neue Therapieoption bei lokal fortgeschrittenem dMMR/MSIhigh Rektumkarzinom
    In: Die Innere Medizin , Jg. 63 2022, Nr. 11, S. 1213 – 1216
    DOI
  • Lorenzen, Sylvie; Quante, Michael; Rauscher, Isabel; Slotta-Huspenina, Julia; Weichert, Wilko; Feith, Marcus; Friess, Helmut; Combs, Stefanie E.; Weber, Wolfgang A.; Haller, Bernhard; Angele, Martin; Albertsmeier, Markus; Blankenstein, Christiane; Kasper, Stefan; Schmid, Roland M.; Bassermann, Florian; Schwaiger, Markus; Liffers, Sven-Thorsten; Siveke, Jens
    PET-directed combined modality therapy for gastroesophageal junction cancer : Results of the multicentre prospective MEMORI trial of the German Cancer Consortium (DKTK)
    In: European Journal of Cancer (EJC) , Jg. 175 2022, S. 99 – 106
    DOI
  • Modest, Dominik Paul; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Müller, Lothar; König, Alexander Otto; Fischer von Weikersthal, Ludwig; Caca, Karel; Kretzschmar, Albrecht; Goekkurt, Eray; Haas, Siegfried; Kurreck, Annika; Stahler, Arndt; Held, Swantje; Jarosch, Armin; Horst, David; Reinacher-Schick, Anke; Kasper, Stefan; Heinemann, Volker; Stintzing, Sebastian; Trarbach, Tanja
    Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in RAS Wild-Type Metastatic Colorectal Cancer : The Randomized PANAMA Trial (AIO KRK 0212)
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 1, S. 72 – 82
    DOI (Open Access)
  • Trojan, Jörg; Hoffmeister, Albrecht; Neu, Bruno; Kasper, Stefan; Dechene, Alexander; Jürgensen, Christian; Schirra, Jörg; Jakobs, Ralf; Palmer, Dan; Selbo, Pål; Olivecrona, Hans; Finnesand, Lena; Høgset, Anders; Walday, Per; Sturgess, Richard
    Photochemical Internalization of Gemcitabine Is Safe and Effective in Locally Advanced Inoperable Cholangiocarcinoma
    In: The Oncologist , Jg. 27 2022, Nr. 6 , S. 430 - 431, e423 - e433
    DOI (Open Access)
  • Kumbrink, Jörg; Bohlmann, Lisa; Mamlouk, Soulafa; Redmer, Torben; Peilstöcker, Daniela; Li, Pan; Lorenzen, Sylvie; Algül, Hana; Kasper, Stefan; Hempel, Dirk; Kaiser, Florian; Michl, Marlies; Bartsch, Harald; Neumann, Jens; Klauschen, Frederick; von Bergwelt-Baildon, Michael; Modest, Dominik Paul; Stahler, Arndt; Stintzing, Sebastian; Jung, Andreas; Kirchner, Thomas; Schäfer, Reinhold; Heinemann, Volker; Holch, Julian W.
    Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer : Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL
    In: Cancers , Jg. 14 2022, Nr. 15, 3631
    DOI (Open Access)
  • Moehler, Markus; Folprecht, Gunnar; Heinemann, Volker; Holch, Julian Walter; Maderer, Annett; Kasper, Stefan; Hegewisch‐Becker, Susanna; Schröder, Jan; Overkamp, Friedrich; Kullmann, Frank; Bechstein, Wolf Otto; Vöhringer, Matthias; Öllinger, Robert; Lordick, Florian; Geißler, Michael; Schulz‐Abelius, Armin; Linz, Bernhard; Bernhard, Helga; Paul, Andreas; Schmidtmann, Irene; Potthoff, Karin; Schimanski, Carl Christoph
    Survival after secondary liver resection in metastatic colorectal cancer : Comparing data of three prospective randomized European trials ( LICC , CELIM , FIRE ‐3)
    In: International Journal of Cancer , Jg. 150 2022, Nr. 8, S. 1341 – 1349
    DOI (Open Access)
  • Guberina, Nika; Kessler, Lukas; Pöttgen, Christoph; Guberina, Maja; Metzenmacher, Martin; Herrmann, Ken; Mucha, Maja; Rischpler, Christoph; Indenkämpen, Frank; Siveke, Jens; Treckmann, Jürgen-Walter; Umutlu, Lale; Kasper, Stefan; Fendler, Wolfgang; Stuschke, Martin
    ⁶⁸Ga]FAPI-PET/CT for radiation therapy planning in biliary tract, pancreatic ductal adeno-, and adenoidcystic carcinomas
    In: Scientific Reports , Jg. 12 2022, Nr. 1, 16261
    DOI, Online Volltext (Open Access)
  • Folprecht, Gunnar; Trautmann, Karolin; Stein, Alexander; Huebner, Gerdt; Stahl, Michael; Kasper, Stefan; Kretzschmar, Albrecht; Köhne, Claus-Henning; Grünwald, Viktor; Hofheinz, Ralf-Dieter; Schütte, Katharina; Löffler, Harald; Bokemeyer, Carsten; Krämer, Alwin
    Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP) : Results of the Phase 2 AIO trial PACET-CUP
    In: British Journal of Cancer (BJC) , Jg. 124 2021, Nr. 4, S. 721 – 727
    DOI (Open Access)
  • Rosery, Vivian; Reis, Henning; Savvatakis, Konstantinos; Kowall, Bernd; Stuschke, Martin; Paul, Andreas; Dechene, Alexander; Yang, JiaJin; Zhao, Ben; Borgers, Arianna; Kasper, Stefan; Schuler, Martin; Cheung, Phyllis F.; Siveke, Jens
    Antitumor immune response is associated with favorable survival in GEP-NEN G3
    In: Endocrine-Related Cancer , Jg. 28 2021, Nr. 10, S. 683 – 693
    DOI
  • Frikkel, Johanna; Beckmann, Mingo B.; de Lazzari, Nico; Götte, Miriam; Kasper, Stefan; Hense, Jörg; Schuler, Martin; Teufel, Martin; Tewes, Mitra
    Changes in fatigue, barriers, and predictors towards physical activity in advanced cancer patients over a period of 12 months : A comparative study
    In: Supportive Care in Cancer , Jg. 29 2021, Nr. 9, S. 5127 – 5137
    DOI (Open Access)
  • Markus, M.; Abendroth, Annalena; Noureddine, R.; Paul, Andreas; Breitenbuecher, Sandra; Virchow, Isabel; Schmid, Kurt Werner; Markus, Peter; Schumacher, Brigitte M.; Wiesweg, Marcel; Wendling, Johanna; Mende, Bastian; Siveke, Jens; Schuler, Martin; Kasper, Stefan
    Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy
    In: Journal of Cancer Research and Clinical Oncology , Jg. 147 2021, Nr. 2, S. 579 – 591
    DOI (Open Access)
  • Pöttgen, Christoph; Gkika, E.; Stahl, Michael; Abu Jawad, Jehad; Gauler, Thomas; Kasper, Stefan; Trarbach, Tanja; Herrmann, Ken; Lehmann, Nils; Jöckel, Karl-Heinz; Lax, H.; Stuschke, Martin
    Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus : mature results of a phase I/II trial
    In: Radiation Oncology , Jg. 16 2021, Nr. 1, S. 59
    DOI, Online Volltext (Open Access)
  • Adamczyk, Alexandra; Pastille, Eva; Kehrmann, Jan; Vu, Vivian P.; Geffers, Robert; Wasmer, Marie-Hélène; Kasper, Stefan; Schuler, Martin; Lange, Christian; Muggli, Beat; Rau, Tilman T.; Klein, Diana; Hansen, Wiebke; Krebs, Philippe; Buer, Jan; Westendorf, Astrid
    GPR15 facilitates recruitment of regulatory T cells to promote colorectal cancer
    In: Cancer Research , Jg. 81 2021, Nr. 11, S. 2970 – 2982
    DOI (Open Access)
  • Pogorzelski, Michael; Hilser, Thomas; Ting, Saskia; Kansy, Benjamin; Gauler, Thomas; Stuschke, Martin; Schmid, Kurt Werner; Lang, Stephan; Grünwald, Viktor; Schuler, Martin; Kasper, Stefan
    Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including Cetuximab
    In: Frontiers in Oncology , Jg. 11 2021, 635096
    DOI, Online Volltext (Open Access)
  • Kasper, Stefan; Foch, Caroline; Messinger, Diethelm; Esser, Regina; Lamy, Francois-Xavier; Rothe, Vivien; Chen, Wenfeng; Cheng, Ann-Lii; Rouyer, Magali; Brodowicz, Thomas; Zielinski, Christoph
    Noninferiority of cetuximab every-2-weeks versus standard once-weekly administration schedule for the first-line treatment of RAS wild-type metastatic colorectal cancer
    In: European Journal of Cancer (EJC) , Jg. 144 2021, S. 291 – 301
    DOI (Open Access)
  • Delord, Jean-Pierre; Argilés, Guillem; Fayette, Jerôme; Wirth, Lori; Kasper, Stefan; Siena, Salvatore; Mesia, Ricard; Berardi, Rossana; Cervantes, Andrés; Dekervel, Jeroen; Zhao, Sylvia; Sun, Yongjian; Hao, Huai-Xiang; Tiedt, Ralph; Vicente, Sergio; Myers, Andrea; Siu, Lillian L.
    A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment
    In: Investigational New Drugs: The Journal of New Anticancer Agents , Jg. 38 2020, S. 1774 – 1783
    DOI
  • Schimanski, Carl Christoph; Kasper, Stefan; Hegewisch-Becker, Susanna; Schröder, Jan; Overkamp, Friedrich; Kullmann, Frank; Bechstein, Wolf Otto; Vöhringer, Matthias; Öllinger, Robert; Lordick, Florian; Heinemann, Volker; Geißler, Michael; Schulz-Abelius, Armin; Bernhard, Helga; Schön, Michael R.; Greil, Richard; Galle, Peter; Lang, Hauke; Schmidtmann, Irene; Moehler, Markus
    Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases : A randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC)
    In: OncoImmunology , Jg. 9 2020, Nr. 1, 1806680
    DOI (Open Access)
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Höhler, Thomas; Reimer, Peter; Steinmetz, Tilman; Berger, Winfried; Linden, Gabriele; Reis, Henning; Markus, Peter; Paul, Andreas; Dechene, Alexander; Schumacher, Brigitte; Kostbade, Karina; Virchow, Isabel; Ting, Saskia; Worm, Karl; Schmid, Kurt Werner; Herold, Thomas; Wiesweg, Marcel; Schuler, Martin; Trarbach, Tanja
    Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer : The CEBIFOX Trial
    In: Clinical Colorectal Cancer , Jg. 19 2020, Nr. 4, S. 236 – 247.e6
    DOI
  • Pape, Ulrich-Frank; Kasper, Stefan; Meiler, Johannes; Sinn, Marianne; Vogel, Arndt; Müller, Lothar; Burkhard, Oswald; Caca, Karel; Heeg, Steffen; Büchner-Steudel, Petra; Rodriguez-Laval, Victor; Kühl, Anja A.; Arsenic, Ruza; Jansen, Holger; Treasure, Peter; Utku, Nalân
    Effcacy and safety of CAP7.1 as second-line treatment for advanced biliary tract cancers : Data from a randomised phase II study
    In: Cancers , Jg. 12 2020, Nr. 11, S. 1 – 16
    DOI (Open Access)
  • Frikkel, Johanna; Götte, Miriam; Beckmann, Mingo B.; Kasper, Stefan; Hense, Jörg; Teufel, Martin; Schuler, Martin; Tewes, Mitra
    Fatigue, barriers to physical activity and predictors for motivation to exercise in advanced Cancer patients
    In: BMC Palliative Care , Jg. 19 2020, Nr. 1, S. 43
    DOI, Online Volltext (Open Access)
  • Becker, Matthias; Böckmann, Britta; Jöckel, Karl-Heinz; Stuschke, Martin; Paul, Andreas; Kasper, Stefan; Virchow, Isabel
    Mapping Patient Data to Colorectal Cancer Clinical Algorithms for Personalized Guideline-Based Treatment
    In: Applied Clinical Informatics , Jg. 11 2020, Nr. 2, S. 200 – 209
    DOI (Open Access)
  • Dechene, Alexander; Kasper, Stefan; Olivecrona, Hans; Schirra, Joerg; Trojan, Joerg
    Photochemical internalization and gemcitabine combined with first-line chemotherapy in perihilar cholangiocarcinoma: observations in three patients
    In: Endoscopy International Open , Jg. 08 2020, Nr. 12, S. E1878 – E1883
    DOI (Open Access)
  • Attenberger, Ulrike; Rödel, Claus; Ghadimi, Michael; Piso, Pompilio; Arnold, Dirk; Folprecht, Gunnar; Geissler, Michael; Hegewisch-Becker, Susanna; Heinemann, Volker; Kasper, Stefan; Modest, Dominik; Reinacher-Schick, Anke; Seufferlein, Thomas; Stein, Alexander; Stintzing, Sebastian; Hofheinz, Ralf-Dieter
    Stellenwert und qualitative Voraussetzungen der Magnetresonanztomografie für die Therapieplanung beim lokal fortgeschrittenen Rektumkarzinom - Interdisziplinäre Empfehlungen
    In: Zeitschrift für Gastroenterologie , Jg. 58 2020, Nr. 6, S. 577 – 582
    DOI
  • Attenberger, U.I.; Rödel, C.; Ghadimi, M.; Piso, P.; Arnold, D.; Folprecht, G.; Geissler, M.; Hegewisch-Becker, S.; Heinemann, V.; Kasper, Stefan; Modest, D.; Reinacher-Schick, A.; Seufferlein, T.; Stein, A.; Stintzing, S.; Hofheinz, R.
    Stellenwert und qualitative Voraussetzungen der Magnetresonanztomographie für die Therapieplanung beim lokal fortgeschrittenen Rektumkarzinom – interdisziplinäre Empfehlungen
    In: Best Practice Onkologie , Jg. 15 2020, Nr. 7-8, S. 300 – 306
    DOI
  • Kasper, Stefan; Virchow, Isabel; Hadaschik, Boris; Radtke, Jan Philipp
    Was erwartet der Nichtradiologe vom Radiologen?
    In: Der Radiologe , Jg. 60 2020, Nr. 5, S. 421 – 429
    DOI
  • Kasper, Stefan; Hussain, Timon; Virchow, Isabel; Stuschke, Martin; Lang, Stephan
    Immunonkologie von Kopf-Hals-Tumoren
    In: HNO , Jg. 67 2019, Nr. 3, S. 221 – 235
    DOI
  • Wiesweg, Marcel; Kasper, Stefan; Worm, Karl; Herold, Thomas; Reis, Henning; Sara, Linda; Metzenmacher, Martin; Abendroth, Annalena; Darwiche, Kaid; Aigner, Clemens; Wedemeyer, Heiner; Helfritz, Fabian A.; Stuschke, Martin; Schumacher, Brigitte; Markus, Peter; Paul, Andreas; Rahmann, Sven; Schmid, Kurt Werner; Schuler, Martin
    Impact of RAS mutation subtype on clinical outcome : A cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer
    In: Oncogene , Jg. 38 2019, Nr. 16, S. 2953 – 2966
    DOI
  • Juntermanns, Benjamin; Kaiser, Gernot Maximil; Reis, Henning; Gries, Silvia; Kasper, Stefan; Paul, Andreas; Canbay, Aliekber; Fingas, Christian
    Long-term Survival after resection for perihilar cholangiocarcinoma : Impact of UICC staging and surgical procedure
    In: The Turkish Journal of Gastroenterology , Jg. 30 2019, Nr. 5, S. 454 – 460
    DOI (Open Access)
  • Abendroth, A.; Noureddine, R.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Schumacher, B.; Wiesweg, Marcel; Köhler, Jens; Markus, M.; Mende, B.; Dechene, Alexander; Schuler, Martin; Kasper, Stefan
    Long-term outcome of patients with advanced pancreatic cancer treated with sequential chemotherapies before the era of modern combination therapy protocols
    In: Journal of Cancer Research and Clinical Oncology , Jg. 145 2019, Nr. 2, S. 445 – 455
    DOI
  • Becker, Matthias; Kasper, Stefan; Böckmann, Britta; Jöckel, Karl-Heinz; Virchow, Isabel
    Natural Language Processing of German Clinical Colorectal Cancer Notes for Guideline-Based Treatment Evaluation
    In: International Journal of Medical Informatics , Jg. 127 2019, S. 141 – 146
    DOI (Open Access)
  • Haddad, Robert; Concha-Benavente, Fernando; Blumenschein, George; Fayette, Jerome; Guigay, Joel; Colevas, A. Dimitrios; Licitra, Lisa; Kasper, Stefan; Vokes, Everett E.; Worden, Francis; Saba, Nabil F.; Tahara, Makoto; Jayaprakash, Vijayvel; Lynch, Mark; Li, Li; Gillison, Maura L.; Harrington, Kevin J.; Ferris, Robert L.
    Nivolumab treatment beyond RECIST‐defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141 : A subgroup analysis of a randomized phase 3 clinical trial
    In: Cancer , Jg. 125 2019, Nr. 18, S. 3208 – 3218
    DOI (Open Access)
  • Al-Batran, Salah-Eddin; Homann, Nils; Pauligk, Claudia; Goetze, Thorsten O.; Meiler, Johannes; Kasper, Stefan; Kopp, Hans-Georg; Mayer, Frank; Haag, Georg Martin; Luley, Kim; Lindig, Udo; Schmiegel, Wolff; Pohl, Michael; Stoehlmacher, Jan; Folprecht, Gunnar; Probst, Stephan; Prasnikar, Nicole; Fischbach, Wolfgang; Mahlberg, Rolf; Trojan, Jörg; Koenigsmann, Michael; Martens, Uwe M.; Thuss-Patience, Peter; Egger, Matthias; Block, Andreas; Heinemann, Volker; Illerhaus, Gerald; Moehler, Markus; Schenk, Michael; Kullmann, Frank; Behringer, Dirk M.; Heike, Michael; Pink, Daniel; Teschendorf, Christian; Löhr, Carmen; Bernhard, Helga; Schuch, Gunter; Rethwisch, Volker; Weikersthal, Ludwig Fischer von; Hartmann, Jörg T.; Kneba, Michael; Daum, Severin; Schulmann, Karsten; Weniger, Jörg; Belle, Sebastian; Gaiser, Timo; Oduncu, Fuat S.; Güntner, Martina; Hozaeel, Wael; Reichart, Alexander; Jäger, Elke; Kraus, Thomas; Mönig, Stefan; Bechstein, Wolf O.; Schuler, Martin; Schmalenberg, Harald; Hofheinz, Ralf D.
    Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4) : A randomised, phase 2/3 trial
    In: Lancet , Jg. 393 2019, Nr. 10184, S. 1948 – 1957
    DOI
  • Pape, Ulrich-Frank; Kasper, Stefan; Meiler, Johannes; Sinn, Marianne; Vogel, Arndt; Mueller, Lothar; Burkhard, Oswald; Caca, Karel; Heeg, Steffen; Laval, Victor Rodriguez; Kühl, Anya A; Arsenic, Ruza; Jansen, Holger; Utku, Nalan
    Randomized phase II trial of the carboxylesterase (CES)-converted novel drug EDO-S7.1 in patients (pts) with advanced biliary tract cancers (BTC)
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. 4_Suppl, S. 264 – 264
    DOI
  • Pastille, Eva; Wasmer, Marie-Hélène; Adamczyk, Alexandra; Vu, Vivian P.; Mager, Lukas F.; Phuong, Nhi Ngo Thi; Palmieri, Vittoria; Simillion, Cedric; Hansen, Wiebke; Kasper, Stefan; Schuler, Martin; Muggli, Beat; McCoy, Kathy D.; Buer, Jan; Zlobec, Inti; Westendorf, Astrid; Krebs, Philippe
    The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer
    In: Mucosal Immunology , Jg. 12 2019, Nr. 4, S. 990 – 1003
    DOI (Open Access)
  • Seufferlein, Thomas; Lausser, Ludwig; Stein, Alexander; Prager, Gerald W.; Kasper, Stefan; Niedermeier, M.; Müller, Lothar; Kubicka, Stefan; König, Alexander O.; Büchner-Steudel, Petra; Wille, Kai; Perkhofer, Lukas; Hann, Alexander; Berger, Andreas W.; Arnold, Dirk; Kestler, Hans Armin; Ettrich, Thomas J.
    A novel biomarker combination and its association with resistance to chemotherapy combinations with bevacizumab : First results of the PERMAD trial
    In: Annals of Oncology , Jg. 29 2018, Nr. Suppl. 8, S. viii159
    DOI (Open Access)
  • Juntermanns, Benjamin; Kaiser, Gernot Maximil; Itani Gutierrez, S.; Heuer, Matthias; Büchter, Matthias; Kahraman, Alisan; Reis, Henning; Kasper, Stefan; Paul, Andreas; Fingas, Christian
    CA19-9 beim intrahepatischen Cholangiokarzinom : Ein diagnostisches und prognostisches Armamentarium?
    In: Der Chirurg , Jg. 89 2018, Nr. 6, S. 466 – 471
    DOI
  • Gillison, Maura L.; Blumenschein, George; Fayette, Jerome; Guigay, Joel; Colevas, A. Dimitrios; Licitra, Lisa; Harrington, Kevin J.; Kasper, Stefan; Vokes, Everett E.; Even, Caroline; Worden, Francis; Saba, Nabil F.; Iglesias Docampo, Lara Carmen; Haddad, Robert; Rordorf, Tamara; Kiyota, Naomi; Tahara, Makoto; Monga, Manish; Lynch, Mark; Li, Li; Ferris, Robert L.
    CheckMate 141 : 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer
    In: The Oncologist , Jg. 23 2018, Nr. 9, S. 1079 – 1082
    DOI (Open Access)
  • Juntermanns, Benjamin; Kaiser, Gernot Maximil; Orth, Lena; Reis, Henning; Jaradat, Derar; Sydor, Svenja; Buechter, Matthias; Kasper, Stefan; Mathé, Zoltan; Sotiropoulos, Georgios Charalambos; Baba, Hideo Andreas; Canbay, Ali; Paul, Andreas; Fingas, Christian
    Comparison of the sixth and the seventh editions of the UICC classification for intrahepatic cholangiocarcinoma
    In: European Journal of Medical Research , Jg. 23 2018, Nr. 1, S. 29
    DOI (Open Access)
  • Kasper, Stefan; Hussain, Timon; Virchow, Isabel; Stuschke, Martin; Lang, Stephan
    Immunonkologie von Kopf-Hals-Tumoren
    In: Best Practice Onkologie , Jg. 13 2018, Nr. 6, S. 336 – 349
    DOI
  • Reis, Henning; Metzenmacher, Martin; Goetz, Moritz; Savvidou, Nikoleta; Darwiche, Kaid; Aigner, Clemens; Herold, Thomas; Eberhardt, Wilfried; Skiba, Charlotte; Hense, Jörg; Virchow, Isabel; Westerwick, Daniela; Bogner, Simon; Ting, Saskia; Kasper, Stefan; Stuschke, Martin; Nensa, Felix; Herrmann, Ken; Hager, Thomas; Schmid, Kurt Werner; Schuler, Martin; Wiesweg, Marcel
    MET Expression in Advanced Non–Small-Cell Lung Cancer : Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy
    In: Clinical Lung Cancer , Jg. 19 2018, Nr. 4, S. e441 – e463
    DOI
  • Ferris, Robert L.; Blumenschein, George; Fayette, Jerome; Guigay, Joel; Colevas, A. Dimitrios; Licitra, Lisa; Harrington, Kevin J.; Kasper, Stefan; Vokes, Everett E.; Even, Caroline; Worden, Francis; Saba, Nabil F.; Docampo, Lara Carmen Iglesias; Haddad, Robert; Rordorf, Tamara; Kiyota, Naomi; Tahara, Makoto; Lynch, Mark; Jayaprakash, Vijayvel; Li, Li; Gillison, Maura L.
    Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck : 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
    In: Oral Oncology , Jg. 81 2018, S. 45 – 51
    DOI (Open Access)
  • Vogel, Arndt; Kasper, Stefan; Bitzer, Michael; Block, Andreas; Sinn, Marianne; Schulze-Bergkamen, Henning; Moehler, Markus; Pfarr, Nicole; Endris, Volker; Goeppert, Benjamin; Merx, Kirsten; Schnoy, Elisabeth; Siveke, Jens; Michl, Patrick; Waldschmidt, Dirk; Kuhlmann, Jan; Geissler, Michael; Kahl, Christoph; Evenkamp, Ralf; Schmidt, Torben; Kuhlmann, Alexander; Weichert, Wilko; Kubicka, Stefan
    PICCA study : panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer—a randomised biomarker-driven clinical phase II AIO study
    In: European Journal of Cancer (EJC) , Jg. 92 2018, S. 11 – 19
    DOI
  • Wiesweg, Marcel; Reis, Henning; Köster, Tobias; Goetz, Moritz; Worm, Karl; Herold, Thomas; Paul, Andreas; Dechene, Alexander; Schumacher, Brigitte; Markus, Peter; Virchow, Isabel; Kostbade, Karina; Wolf, Nathalie; Zaun, Gregor; Metzenmacher, Martin; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Phosphorylation of p70 Ribosomal Protein S6 Kinase β-1 is an Independent Prognostic Parameter in Metastatic Colorectal Cancer
    In: Clinical Colorectal Cancer , Jg. 17 2018, Nr. 2, S. e331 – e352
    DOI
  • Trojan, Jörg; Sturgess, R.; Harrison Palmer, D.; Neu, Bruno; Kasper, Stefan; Dechene, Alexander; Jürgensen, C.; Schirra, J.; Jakobs, Ralf Gerhard; Högset, Anders; Finnesand, L.; Olivecrona, H.
    PhotoChemical internalization of gemcitabine followed by gemcitabine/cisplatin in perihilar cholangiocarcinoma : Results from a phase I dose escalation trial
    In: Annals of Oncology , Jg. 29 2018, Nr. Suppl. 8, S. viii259 – viii260
    DOI (Open Access)
  • Kasper, Stefan; Kisro, Jens; Fuchs, Martin; Müller, Christian; Schulz-Abelius, Armin; Karthaus, Meinolf; Rafiyan, Mohammad-Reza; Stein, Alexander
    Safety profile of trifluridine/tipiracil monotherapy in clinical practice : results of the German compassionate-use program for patients with metastatic colorectal cancer
    In: BMC Cancer , Jg. 18 2018, S. 1124
    DOI (Open Access)
  • Soulières, Denis; Faivre, Sandrine; Mesía, Ricard; Remenár, Éva; Li, Shau-Hsuan; Karpenko, Andrey; Dechaphunkul, Arunee; Ochsenreither, Sebastian; Kiss, Laura Anna; Lin, Jin-Ching; Nagarkar, Raj; Tamás, László; Kim, Sung-Bae; Erfán, Jozsef; Alyasova, Anna; Kasper, Stefan; Barone, Carlo; Turri, Sabine; Chakravartty, Arunava; Chol, Marie; Aimone, Paola; Hirawat, Samit; Licitra, Lisa
    Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1) : a randomised, double-blind, placebo-controlled phase 2 trial
    In: The Lancet Oncology , Jg. 18 2017, Nr. 3, S. 323 – 335
    DOI
  • Concha-Benavente, F.; Gillison, M. L.; Blumenschien, G.; Harrington, K. J.; Fayette, J.; Colevas, A. D.; Licitra, L.; Kasper, Stefan; Even, C.; Worden, F.; Saba, N. F.; Haddad, R.; Tahara, M.; Hasegawa, Y.; Yen, C. J.; Lynch, M.; Monga, M.; Geese, W. J.; Vokes, E. E.; Ferris, R. L.
    Characterisation of Potential Predictive Biomarkers of Response to Nivolumab in Checkmate 141 in Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    In: Asia-Pacific Journal of Clinical Oncology , Jg. 13 4 2017, S. 141 – 141
  • Breitenbücher, Frank; Von Pawel, Joachim; Sebastian, Martin; Kortsik, Cornelius; Ting, Saskia; Kasper, Stefan; Wohlschläger, Jeremias; Worm, Karl; Morresi-Hauf, Alicia; Schad, Arno; Westerwick, Daniela; Wehler, Beatrice; Werner, Martin; Munzert, Gerd; Gaschler-Markefski, Birgit; Schmid, Kurt Werner; Schuler, Martin
    Comprehensive biomarker analyses in patients with advanced or metastatic non-small cell lung cancer prospectively treated with the polo-like Kinase 1 Inhibitor BI2536
    In: Oncology Research and Treatment , Jg. 40 2017, Nr. 7-8, S. 435 – 439
    DOI
  • Al-Batran, S. E.; Pauligk, C.; Homann, N.; Schmalenberg, H.; Kopp, H. G.; Haag, G. M.; Luley, K.; Folprecht, G.; Probst, S.; Thuss-Patience, P.; Trojan, J.; Koenigsmann, M.; Lindig, U.; Pohl, M.; Kasper, Stefan; Hler, M. M.; Goetze, T.; Schuler, Martin; Jaeger, E.; Hofheinz, R. D.
    Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) for resectable esophagogastric cancer : Updated results from multicenter, randomized phase 3 FLOT4-AIO trial (German Gastric Group at AIO)
    In: Annals of Oncology , Jg. 28 2017, Nr. Suppl. 5
  • Wiesweg, Marcel; Eberhardt, Wilfried; Reis, Henning; Ting, Saskia; Savvidou, Nikoleta; Skiba, Charlotte; Herold, Thomas; Christoph, Daniel; Meiler, Johannes; Worm, Karl; Kasper, Stefan; Theegarten, Dirk; Hense, Jörg; Hager, Thomas; Darwiche, Kaid; Oezkan, Filiz; Aigner, Clemens; Welter, Stefan; Kühl, Hilmar; Stuschke, Martin; Schmid, Kurt Werner; Schuler, Martin
    High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer
    In: Journal of Thoracic Oncology , Jg. 12 2017, Nr. 1, S. 54 – 64
    DOI (Open Access)
  • Kasper, Stefan; Reis, Henning; Ziegler, Sophie; Nothdurft, Silke; Mueller, Andre; Goetz, Moritz; Wiesweg, Marcel; Phasue, Jeannette; Ting, Saskia; Wieczorek, Sarah; Even, Anna; Worm, Karl; Pogorzelski, Michael; Breitenbuecher, Sandra; Meiler, Johannes; Paul, Andreas; Trarbach, Tanja; Schmid, Kurt Werner; Breitenbücher, Frank; Schuler, Martin
    Molecular dissection of effector mechanisms of RAS-mediated resistance to anti-EGFR antibody therapy
    In: OncoTarget , Jg. 8 2017, Nr. 28, S. 45898 – 45917
    DOI (Open Access)
  • Harrington, Kevin J; Ferris, Robert L; Blumenschein, George; Colevas, A Dimitrios; Fayette, Jérôme; Licitra, Lisa; Kasper, Stefan; Even, Caroline; Vokes, Everett E; Worden, Francis; Saba, Nabil F; Kiyota, Naomi; Haddad, Robert; Tahara, Makoto; Grünwald, Viktor; Shaw, James W; Monga, Manish; Lynch, Mark; Taylor, Fiona; DeRosa, Michael; Morrissey, Laura; Cocks, Kim; Gillison, Maura L; Guigay, Joël
    Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141) : health-related quality-of-life results from a randomised, phase 3 trial
    In: The Lancet Oncology , Jg. 18 2017, Nr. 8, S. 1104 – 1115
    DOI (Open Access)
  • Al-Batran, S. E.; Pauligk, C.; Homann, N.; Schmalenberg, H.; Kopp, H. G.; Haag, G. M.; Luley, K. B.; Schmiegel, W.; Folprecht, G.; Probst, S.; Prasnikar, N.; Thuss-Patience, P.; Fischbach, W.; Trojan, J.; Koenigsmann, M.; Goetze, T. O.; Kraus, T. W.; Battmann, A.; Moenig, S. P.; Bechstein, W.; Gaiser, T.; Tannapfel, A.; Jäger, E.; Schuler, Martin; Lindig, U.; Pohl, M.; Kasper, Stefan; Möhler, M.; Hofheinz, R. D.
    Perioperative chemotherapy with docetaxel, oxaliplatin and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO) : a rando
    In: Oncology Research and Treatment , Jg. 40 2017, Nr. Suppl. 3: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Stuttgart, 29. September-3. Oktober 2017: Abstracts, S. 200 – 201
    DOI
  • Sturgess, R.; Finnesand, L.; Trojan, J.; Jürgensen, C.; Palmer, D.; Høgset, A.; Jakobs, R.; Hoffmeister, A.; Neu, B.; Kasper, Stefan; Schirra, J.; Dechene, Alexander
    Phase I clinical study with photochemical internalisation, a novel technology for treatment of perihilar cholangiocarcinoma
    In: Journal of Hepatology , Jg. 66 2017, Nr. 1, S. S452
    DOI
  • Kalkavan, Halime; Sharma, Piyush; Kasper, Stefan; Helfrich, Iris; Pandyra, Aleksandra A.; Gassa, Asmae; Virchow, Isabel; Flatz, Lukas; Brandenburg, Tim; Namineni, Sukumar; Heikenwalder, Mathias; Höchst, Bastian; Knolle, Percy A.; Wollmann, Guido; Von Laer, Dorothee; Drexler, Ingo; Rathbun, Jessica; Cannon, Paula M.; Scheu, Stefanie; Bauer, Jens; Chauhan, Jagat; Häussinger, Dieter; Willimsky, Gerald; Löhning, Max; Schadendorf, Dirk; Brandau, Sven; Schuler, Martin; Lang, Philipp A.; Lang, Karl S.
    Spatiotemporally restricted arenavirus replication induces immune surveillance and type i interferon-dependent tumour regression
    In: Nature Communications , Jg. 8 2017, S. 14447
    DOI (Open Access)
  • Kasper, Stefan; Haddad, R.; Ferris, R. L.; Blumenschein, G.; Fayette, J.; Guigay, J.; Colevas, A. D.; Licitra, L.; Vokes, E. E.; Worden, F.; Saba, N. F.; Tahara, M.; Monga, M.; Lynch, M.; Zhu, J.; Shaw, J. W.; Gillison, M. L.; Harrington, K. J.
    Treatment beyond progression with nivolumab (nivo) in patients with recurrent or metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN) in the phase 3 CheckMate 141 study
    In: Oncology Research and Treatment , Jg. 40 2017, Nr. Suppl. 3, S. 250 – 251
  • Dechene, Alexander; Kasper, Stefan
    Cholangiozelluläres Karzinom : Interventionelle und systemische Therapieoptionen
    In: Der Gastroenterologe , Jg. 11 2016, Nr. 5, S. 400 – 409
    DOI
  • Köhler, Jens; Schuler, Martin; Gauler, Thomas; Nöpel-Dünnebacke, Stefanie; Ahrens, Maike; Hoffmann, Andreas-Claudius; Kasper, Stefan; Nensa, Felix; Gomez, Benedikt; Hahnemann, Maria; Breitenbücher, Frank; Cheufou, Danjouma; Özkan, Filiz; Darwiche, Kaid; Hoiczyk, Mathias; Reis, Henning; Welter, Stefan; Eberhardt, Wilfried; Eisenacher, Martin; Teschler, Helmut; Stamatis, Georgios; Schmiegel, Wolff; Hahn, Stephan Albrecht; Baraniskin, Alexander
    Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
    In: Journal of Cancer Research and Clinical Oncology , Jg. 142 2016, Nr. 4, S. 795 – 805
    DOI
  • Stintzing, S.; Modest, D. P.; Jung, A.; Kirchner, T.; Schafer, R.; Sers, C.; Hildebrandt, B.; Daum, S.; Folprecht, G.; Schuler, Martin; Kasper, Stefan; Trojan, J.; Jaeger, D.; Schulze-Bergkamen, H.; von Weikersthal, L. F.; Schalhorn, A.; Heinemann, V.
    Differences in gene-expression in mCRC tissue samples with regard to tumor location and used chemotherapeutic substances : Data of the FIRE-1 study
    In: Journal of Clinical Oncology (JCO) , Jg. 34 2016, Nr. Suppl. 4, S. 562
    DOI
  • Juntermanns, B; Fingas, Christian; Sotiropoulos, Georgios; Jaradat, D; Dechene, Alexander; Reis, H; Kasper, Stefan; Paul, Andreas; Kaiser, Gernot Maximil
    Klatskin-Tumor : Langzeitüberleben nach Operation
    In: Der Chirurg , Jg. 87 2016, Nr. 6, S. 514 – 519
    DOI
  • Ferris, Robert L; Blumenschein, George; Fayette, Jerome; Guigay, Joel; Colevas, A Dimitrios; Licitra, Lisa; Harrington, Kevin; Kasper, Stefan; Vokes, Everett E; Even, Caroline; Worden, Francis; Saba, Nabil F; Iglesias Docampo, Lara C; Haddad, Robert; Rordorf, Tamara; Kiyota, Naomi; Tahara, Makoto; Monga, Manish; Lynch, Mark; Geese, William J; Kopit, Justin; Shaw, James W; Gillison, Maura L
    Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
    In: The New England Journal of Medicine , Jg. 375 2016, Nr. 19, S. 1856 – 1867
    DOI (Open Access)
  • Modest, D.P.; Kasper, Stefan; Stintzing, S.; Prasnikar, N.; Müller, L.; Caca, K.; Gökkurt, E.; von Weikersthal, L. Fischer; Kopp, H.-G.; Trarbach, Tanja
    Randomized phase II study of maintenance treatment with 5-FU/FA plus panitumumab vs 5-FU/FA alone after induction (mFOLFOX6 plus panitumumab) in patients with RAS WT metastatic colorectal cancer
    In: Annals of Oncology , Jg. 27 2016, Nr. Suppl. 6, S. 605TiP
    DOI
  • Utku, Nalan; Kuhlmann, Jan; Kasper, Stefan; Pape, Ulrich-Frank; Vogel, Arndt; Sinn, Marianne; Keilholz, Ulrich; Caca, Karel
    Randomized, multicenter phase II trial of CAP7.1 in patients with advanced biliary tract cancers.
    In: Journal of Clinical Oncology (JCO) , Jg. 34 2016, Nr. Suppl. 4, S. 441 – 441
    DOI
  • Hoya, V.; Stuschke, Martin; Sauerwein, Wolfgang; Bornfeld, Norbert; Metz, Klaus; Schuler, Martin; Kasper, Stefan
    Small cell neuroendocrine carcinoma of the right eye : A case report
    In: Oncology Research and Treatment , Jg. 39 2016, Nr. Suppl. 3, S. 189 – 189
  • Klümpen, H.J.; Nashan, B.; Shannon, J.; Primrose, J.; Kasper, Stefan; Goldstein, D.; Wege, H.; Sinn, M.; Arnold, D.; Stein, A.; Weiss, K.H.; Bechstein, W.O.; Rentsch, M.; Bridgewater, J.; Jensen, L.H.; Kunzmann, V.; Lindig, U.; Lohse, A.W.
    Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1) – a randomized, multidisciplinary, multinational phase III trial
    In: Journal of Hepatology , Jg. 62 2015, Nr. Suppl. 2, S. S845
    DOI
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Hoehler, Thomas; Reimer, Peter; Steinmetz, Tilman; Berger, Winfried; Linden, Gabriele; Ting, Saskia; Markus, Peter; Paul, Andreas; Dechene, Alexander; Schumacher, Brigitte; Kosbade, Karina; Worm, Karl; Schmid, Kurt Werner; Herold, Thomas; Schuler, Martin; Trarbach, Tanja
    Cetuximab biweekly plus mFOLFOX6 as first-line therapy in patients (pts) with KRAS wild-type (wt) (exon 2) metastatic colorectal cancer (mCRC) : Primary endpoint and subgroup analysis of the CEBIFOX trial
    In: Journal of Clinical Oncology (JCO) , Jg. 33 2015, Nr. 15 Suppl., S. 3568
    DOI
  • Reis, Henning; Herold, Thomas; Ting, S.; Worm, Karl Heinz; Huber, U.; Christoph, Daniel; Eberhardt, Wilfried; Kostbade, K.; Kasper, Stefan; Stamatis, Georgios; Welter, Stefan; Darwiche, Kaid; Karpf-Wissel, Rüdiger; Theegarten, Dirk; Schmidt, K. W.; Schuler, Martin; Wiesweg, Marcel
    HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomas
    In: Lung Cancer , Jg. 88 2015, Nr. 1, S. 34 – 41
    DOI
  • Pogorzelski, M.; Ting, Saskia; Gauler, Thomas; Breitenbücher, Frank; Vossebein, I.; Hoffarth, S.; Markowetz, J.; Lang, Stephan; Bergmann, Christoph; Brandau, Sven; Abu-Jawad, J.; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Molecular dissection of the impact of frequent genetic alterations on the response of head and neck cancers to anti-epidermal growth factor receptor-directed therapies
    In: Oral Oncology , Jg. 51 2015, Nr. 5, S. e39
    DOI
  • Breitenbücher, Frank; Hoffarth, Sandra; Worm, Karl; Cortes-Incio, Diana; Gauler, Thomas; Köhler, Jens; Herold, Thomas; Kurt Werner, Schmid; Freitag, Lutz; Kasper, Stefan; Schuler, Martin
    Development of a Highly Sensitive and Specific Method for Detection of Circulating Tumor Cells Harboring Somatic Mutations in Non-Small-Cell Lung Cancer Patients
    In: PLoS ONE , Jg. 9 2014, Nr. 1, e85350
    DOI (Open Access)
  • Göbel, C.; Breitenbücher, Frank; Kalkavan, Halime; Hähnel, Patricia S.; Kasper, Stefan; Hoffarth, Christian; Merches, Katja; Schild, Hans-Jörg; Lang, Karl S.; Schuler, Martin
    Functional expression cloning identifies COX-2 as a suppressor of antigen-specific cancer immunity
    In: Cell Death and Disease , Jg. 5 2014, Nr. 12, 1568
    DOI (Open Access)
  • Pogorzelski, M-; Ting, Saskia; Gauler, Thomas; Breitenbücher, Frank; Vossebein, I.; Hoffarth, S.; Markowetz, J.; Lang, S.; Bergmann, Christoph; Brandau, Sven; Abu Jawad, Jehad; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy
    In: Cell Death and Disease , Jg. 5 2014, Nr. 2, e1091
    DOI (Open Access)
  • Kasper, Stefan; Schuler, Martin
    Targeted therapies in gastroesophageal cancer
    In: European Journal of Cancer (EJC) , Jg. 50 2014, Nr. 7, S. 1247 – 1258
    DOI
  • Pastille, Eva; Bardini, Katrin; Fleissner, Diana; Adamczyk, Alexandra; Frede, Annika; Wadwa, Munisch; Smolinski, Dorthe von; Kasper, Stefan; Sparwasser, Tim; Gruber, Achim D.; Schuler, Martin; Sakaguchi, Shimon; Roers, Axel; Müller, Werner; Hansen, Wiebke; Buer, Jan; Westendorf, Astrid
    Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer
    In: Cancer Research , Jg. 74 2014, Nr. 16, S. 4258 – 4269
    DOI
  • Caldarelli, Antonio; Müller, Jörg P.; Paskowski-Rogacz, M.; Herrmann, Ken; Bauer, Reinhard F.; Koch, Sina; Heninger, Anne Kristin; Krastev, Dragomir Blazhev; Ding, Li; Kasper, Stefan; Fischer, Thomas A.; Brodhun, Michael; Böhmer, Frank Dietmar; Buchholz, Frank
    A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling
    In: Leukemia , Jg. 27 2013, Nr. 12, S. 2301 – 2310
    DOI
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Hoehler, T.; Reimer, P.; Steinmetz, T.; Berger, W.; Linden, G.; Ting, Saskia; Markus, P.; Paul, Andreas; Schuler, Martin; Trarbach, Tanja
    Cetuximab biweekly plus mFOLFOX6 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC) : An interim analysis of the CEBIFOX trial
    In: Journal of Clinical Oncology (JCO) , Jg. 31 2013, Nr. 15 Suppl., S. e14502
    DOI
  • Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, Karl; Kasper, Stefan; Tewes, Mitra; Welt, Anja; Richly, Heike; Meiler, Johannes; Bauer, Sebastian; Hense, Jörg; Gauler, Thomas; Köhler, Jens; Eberhardt, Wilfried; Darwiche, Kaid; Freitag, Lutz; Stamatis, Georgios; Breitenbücher, Frank; Wohlschläger, Jeremias; Theegarten, Dirk; Derks, Cordula; Cortes-Incio, Diana; Linden, Gabriele; Skottky, Silke; Lütkes, Peter; Dechene, Alexander; Paul, Andreas; Markus, Peter; Schmid, Kurt Werner; Schuler, Martin
    Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center
    In: European Journal of Cancer (EJC) , Jg. 49 2013, Nr. 15, S. 3076 – 3082
    DOI
  • Kasper, Stefan; Breitenbücher, Frank; Reis, Henning; Brandau, Sven; Worm, K.; Köhler, J.; Paul, Andreas; Trarbach, Tanja; Schmid, Kurt Werner; Schuler, Martin
    Oncogenic RAS simultaneously protects against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR signaling blockade
    In: Oncogene , Jg. 32 2013, Nr. 23, S. 2873 – 2881
    DOI
  • Welt, Anja; Tewes, Mitra; Aktas, Bahriye; Hoffmann, Oliver; Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, Karl; Richly, Heike; Hense, Jörg; Palmer, Michael R.; Lee, Benjamin H.; Wendling, Johanna; Kossow, Josef; Scheulen, Max Ernst; Lehnerdt, Cathrin; Kohl, Marzena; Derks, Cordula; Skottky, Silke; Haus, Ulrike; Schmid, Kurt Werner; Kimmig, Rainer; Schuler, Martin; Kasper, Stefan
    Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients
    In: Breast Cancer Research and Treatment , Jg. 142 2013, Nr. 1, S. 81 – 88
    DOI
  • Molzan, M.; Kasper, Stefan; Röglin, L.; Skwarczynska, M.; Sassa, T.; Inoue, T.; Breitenbücher, Frank; Ohkanda, J.; Kato, N.; Schuler, Martin; Ottmann, C.
    Stabilization of Physical RAF/14-3-3 Interaction by Cotylenin A as Treatment Strategy for RAS Mutant Cancers
    In: ACS Chemical Biology , Jg. 8 2013, Nr. 9, S. 1869 – 1875
    DOI
  • Kasper, Stefan; Meiler, Johannes; Schuler, Martin
    Antikörper zur adoptiven Immuntherapie solider Tumoren
    In: Der Onkologe , Jg. 18 2012, Nr. 9, S. 757 – 769
    DOI
  • Pogorzelski, M.; Ting, Saskia; Gauler, Thomas; Vossebein, I.; Breitenbucher, F.; Lang, Stephan; Hoffmann, T. K.; Bergmann, Christoph; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Impact of HPV status on the response of head and neck cancers to the anti-EGFR antibody cetuximab
    In: Onkologie , Jg. 35 2012, Nr. Suppl. 6, S. 193 – 193
  • Schimanski, Carl C.; Möhler, Markus; Schön, Michael; van Cutsem, Eric; Greil, Richard; Bechstein, Wolf O.; Hegewisch-Becker, Susanna; von Wichert, Götz; Vöhringer, Matthias; Heike, Michael; Heinemann, Volker; Peeters, Marc; Kanzler, Stephan; Kasper, Stefan; Overkamp, Friedrich; Schröder, Jan; Seehofer, Daniel; Kullmann, Frank; Linz, Bernhard; Schmidtmann, Irene; Smith-Machnow, Victoria; Gockel, Ines; Lang, Hauke; Galle, Peter R.
    LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases-a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial
    In: BMC Cancer , Jg. 12 2012, S. 144
    DOI (Open Access)
  • Markova, Boyka; Hähnel, Patricia S.; Kasper, Stefan; Herbertz, Stephan; Schuler, Martin; Breitenbücher, Frank
    Pharmacologic inhibition of mTOR antagonizes the cytotoxic activity of pemetrexed in non-small cell lung cancer
    In: Journal of Cancer Research and Clinical Oncology , Jg. 138 2012, Nr. 4, S. 545 – 554
    DOI
  • Kasper, Stefan; Breitenbücher, Frank; Heidel, F.; Hoffarth, S.; Markova, B.; Schuler, Martin; Fischer, T.
    Targeting MCL-1 sensitizes FLT3-ITD-positive leukemias to cytotoxic therapies
    In: Blood Cancer Journal , Jg. 2 2012, Nr. 3, S. e60
    DOI (Open Access)
  • Kasper, Stefan; Reis, Henning; Breitenbücher, Frank; Markowetz, J.; Pogorzelski, M.; Trarbach, Tanja; Worm, K.; Schmid, Kurt Werner; Schuler, Martin
    Targeting the anti-apoptotic protein BCL-XL to overcome RAS mediated resistance to anti-EGFR antibody therapy in colorectal cancer
    In: Onkologie , Jg. 35 2012, Nr. Suppl. 6, S. 253
  • Wiesweg, Marcel; Kasper, Stefan; Wohlschläger, Jeremias; Ting, Saskia; Skottky, S.; Worm, K.; Derks, C.; Tewes, Mitra; Breitenbücher, Frank; Gauler, Thomas; Eberhardt, Wilfried; Ahrens, M.; Hoiczyk, M.; Meiler, Johannes; Hense, Jörg; Welt, Anja; Theegarten, Dirk; Freitag, Lutz; Kimmig, Rainer; Schmid, Kurt Werner; Schuler, Martin
    VVTZ-Tumorprofil - First results of a preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center
    In: Onkologie , Jg. 35 2012, Nr. Suppl. 6, S. 204 – 204
  • Christoph, Daniel; Kasper, Stefan; Gauler, Thomas; Loesch, Christian; Engelhard, Marianne; Theegarten, Dirk; Pöttgen, Christoph; Hepp, Rodrigo; Peglow, Anja; Loewendick, Heike; Welter, Stefan; Stamatis, Georgios; Hirsch, Fred R.; Schuler, Martin; Eberhardt, Wilfried; Wohlschläger, Jeremias
    Βv-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer
    In: British Journal of Cancer (BJC) , Jg. 107 2012, Nr. 5, S. 823 – 830
    DOI (Open Access)
  • Aktas, B.; Kasimir-Bauer, Sabine; Kasper, Stefan; Derks, C.; Kimmig, Rainer; Schuler, Martin; Tewes, Mitra
    Comparison of PIK3CA Hot Spot Mutations in the Primary Tumor or Metastases with PIK3CA Mutations or PIK3CA Over-Expression in Circulating Tumor Cells of Metastatic Breast Cancer Patients under Sequential Palliative Therapy
    In: Cancer Research , Jg. 71 2011, Nr. Suppl. 24
    DOI
  • Christoph, DanielC; Kasper, Stefan; Gauler, ThomasC; Breitenbücher, Frank; Engelhard, Marianne; Theegarten, Dirk; Pöttgen, Christoph; Hepp, Rodrigo; Peglow, Anja; Loewendick, Heike; Hirsch, FredR; Schuler, Martin; Eberhardt, Wilfried; Wohlschläger, Jeremias
    Evaluation of Betav-Tubulin expression as novel predictive biomarker for clinical benefit from treatment with taxanes in non-small cell lung cancer
    In: Journal of Thoracic Oncology , Jg. 6 2011, Nr. Suppl. 6, S. 1078
  • Kasper, Stefan; Breitenbücher, Frank; Even, A.; Pogorzelski, M.; Hoffarth, S.; Stergar, S. L.; Trarbach, Tanja; Schuler, Martin
    Pharmacological Inhibition of NF-k and PLK-1 to the Opening of the RAS-mediated Resistance to anti-EGFR Antibody therapies in Colorectal cancer *
    In: Der Internist , Jg. 52 2011, Nr. 6, S. 726 – 726
  • Schuler, Martin; Breitenbücher, Frank; Trarbach, Tanja; Brandau, Sven; Schmid, Kurt Werner; Kasper, Stefan
    Simultaneous protection against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR-signaling blockade by oncogenic RAS
    In: Journal of Clinical Oncology (JCO) , Jg. 29 2011, Nr. Suppl. 4, S. 440
    DOI

    • Vorworte / Nachworte

  • Kasper, Stefan; Rammensee, Hans-Georg; Gaipl, Udo; Höffken, Klaus
    Tumor immunology : The new fourth pillar of tumor treatment
    In: Der Onkologe , Jg. 27 2021, Nr. 11, S. 1046 – 1048
    DOI (Open Access)

    • Abstracts

  • Kasper, Stefan; Sartore-Bianchi, Andrea; Randrian, Violaine; Cremolini, Chiara; Arnold, Dirk; Dasari, Arvind; Eng, Cathy; Lonardi, Sara; Elez, Elena; Yoshino, Takayuki; Sobrero, Alberto F.; Yao, James C.; Hochster, Howard S.; Van Cutsem, Eric; Tougeron, David; Yu, Ziji; Dong, Cynthia; Schelman, William R.; Ghiringhelli, François
    Fruquintinib plus best supportive care for patients with metastatic colorectal cancer : Characterization of patients who had an overall survival of ≥10 months in the FRESCO-2 study
    2025 ASCO Gastrointestinal Cancers Symposium; January 23-25, 2025; San Francisco, USA,
    In: Journal of Clinical Oncology (JCO) , Jg. 43 2025, Nr. 4_suppl, S. 142 – 142
    DOI (Open Access)
  • Ballhausen, Alexej; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Müller, Lothar; Koenig, Alexander; Von Weikersthal, Ludwig Fischer; Sommerhäuser, Greta; Jelas, Ivan; Alig, Annabel Helga Sophie; Kurreck, Annika; Stahler, Arndt; Goekkurt, Eray; Held, Swantje; Kasper, Stefan; Heinrich, Kathrin; Heinemann, Volker; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik Paul
    Dermatology-related quality of life outcomes in patients with RAS wild-type (wt) metastatic colorectal cancer (mCRC) treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction : A prespecified secondary analysis of the phase 2 randomized PanaMa (AIO KRK 0212) trial
    In: Journal of Clinical Oncology (JCO) , Jg. 42 2024, Nr. Suppl. 16, e15539
    DOI (Open Access)
  • Modest, Dominik Paul; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Müller, Lothar; Koenig, Alexander; Fischer von Weikersthal, Ludwig; Caca, Karel; Goekkurt, Eray; Haas, Siegfried; Kurreck, Annika; Held, Swantje; Jarosch, Armin; Horst, David; Reinacher-Schick, Anke C.; Kasper, Stefan; Heinemann, Volker; Stintzing, Sebastian; Trarbach, Tanja; Stahler, Arndt
    FU/FA maintenance therapy with or without panitumumab (pmab) in RAS wild-type metastatic colorectal cancer (mCRC) (PanaMa, AIO KRK 0212) : Updated efficacy analyses
    In: Journal of Clinical Oncology (JCO) , Jg. 42 2024, Nr. Suppl. 16, 3506
    DOI (Open Access)
  • Kestler, Hans A.; Ettrich, Thomas Jens; Stein, Alexander; Arnold, Dirk; Prager, Gerald W.; Kasper, Stefan; Niedermeier, Michael; Müller, Lothar; Kubicka, Stefan; Koenig, Alexander; Buechner-Steudel, Petra; Berger, Andreas; Wille, Kai; Kestler, Angelika; Kraus, Johann M.; Werle, Silke; Perkhofer, Lukas; Lausser, Ludwig; Seufferlein, Thomas
    Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer using a multi-marker panel and a machine-learning approach : Final results of the prospective multicenter PERMAD trial
    In: Journal of Clinical Oncology (JCO) , Jg. 42 2024, Nr. Suppl. 3, S. 204 – 204
    DOI
  • Stintzing, Sebastian; Tabernero, Josep; Satoh, Taroh; Dasari, Arvind; Lonardi, Sara; Eng, Cathy; Garcia-Carbonero, Rocio; Elez, Elena; Yoshino, Takayuki; Sobrero, Alberto F.; Yao, James C.; Kasper, Stefan; Arnold, Dirk; Basic, Edin; Granold, Matthias; Petschulies, Marco; Wu, Liwen; Chen, Lucy; Yang, Zhao; Van Cutsem, Eric
    Quality-adjusted time without symptoms of disease or toxicity (Q-TWiST) analysis of fruquintinib + best supportive care (BSC) compared with placebo + BSC in metastatic colorectal cancer (mCRC) : Results from the FRESCO-2 trial
    In: Journal of Clinical Oncology (JCO) , Jg. 42 2024, Nr. Suppl. 3, 116
    DOI
  • Stockey, M.; Treckmann, Jürgen-Walter; Rink, A.; Schmidt, H.; Markus, Peter; Albers, David; Zaun, G.; Kostbade, K.; Hilser, T.; Pogorzeslki, M.; Baba, Hideo Andreas; Wiesweg, Marcel; Schuler, Martin; Kasper, Stefan; Virchow, I.
    HER2-low as potential prognostic biomarker in patients (pts) with metastatic or recurrent Gastric Cancer (GC) or esophageal-gastric junction (AEG) adenocarcinoma
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment , Jg. 46 2023, Nr. Supplement 5: DGHO Abstracts, S. 117 – 118
    DOI (Open Access)
  • Hoppe, Beeke; Modest, Dominik Paul; Keilholz, Luisa; Na, Il-Kang; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Von Weikersthal, Ludwig Fischer; Goekkurt, Eray; Reinacher-Schick, Anke C.; Kasper, Stefan; Kind, Andreas Jay; Kurreck, Annika; Held, Swantje; Heinemann, Volker; Horst, David; Jarosch, Armin; Stintzing, Sebastian; Trarbach, Tanja; Stahler, Arndt
    Consensus molecular subtypes (CMS) as prognostic and predictive biomarkers of panitumumab (Pmab), fluorouracil and folinic acid (FU/FA) or FU/FA maintenance therapy following Pmab-FOLFOX induction in RAS wildtype metastatic colorectal cancer (mCRC) : PANAMA trial (AIO-KRK-0212)
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 16_Suppl., S. 3537
    DOI
  • Kind, Andreas Jay; Modest, Dominik Paul; Sers, Christine; Mamlouk, Soulafa; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Von Weikersthal, Ludwig Fischer; Goekkurt, Eray; Reinacher-Schick, Anke C.; Kasper, Stefan; Kurreck, Annika; Hoppe, Beeke; Held, Swantje; Heinemann, Volker; Horst, David; Jarosch, Armin; Stintzing, Sebastian; Trarbach, Tanja; Stahler, Arndt
    Negative hyperselection for mutations associated with anti-EGFR antibody resistance in RAS wildtype metastatic colorectal cancer (mCRC) : Evaluation of the PANAMA trial (AIO-KRK-0212, maintenance therapy with 5-FU, folinic acid (FU/FA) with or without panitumumab)
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 16_Suppl., S. 3536
    DOI
  • Segal, N.; Rivera, F.; Tournigand, C.; Kasper, Stefan; Chen, Y.; Deshpande, P.; Messmann, R.; Kopetz, S.
    P-23 Phase II study (daNIS-3) of the anti–TGF-β monoclonal antibody NIS793 and other new investigational drug combinations with standard-of-care therapy vs standard-of-care alone in patients with second-line metastatic colorectal cancer
    In: Annals of Oncology , Jg. 33 2022, S. 254 – S255
    DOI (Open Access)
  • Civan, C.; Kasper, Stefan; Berliner, C.; Fragoso-Costa, Pedro; Grünwald, Viktor; Pogorzelski, M.; Schaarschmidt, B. M.; Lang, Stephan; Kersting, David; Nader, M.; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang P.; Weber, Manuel
    PSMA-directed imaging and therapy of salivary gland tumors : a single-center retrospective study
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 49 2022, Nr. Supplement 1, S. S229
    DOI (Open Access)
  • Kurreck, Annika; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Mueller, Lothar; Koenig, Alexander; von Weikersthal, Ludwig; Goekkurt, Eray; Haas, Siegfried; Stahler, Arndt; Heinemann, Volker; Held, Swantje; Alig, Annabel Helga Sophie; Hoppe, Beeke; Kind, Andreas Jay; Kasper, Stefan; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik Paul
    Predictive and prognostic value of carcinoembryonic antigen (CEA) on maintenance therapy with 5-fluoruracil/leucovorin plus panitumumab or 5-fluoruracil/leucovorin alone in RAS wildtype metastatic colorectal cancer : Evaluation of the phase II PanaMa trial (AIO KRK 0212)
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 16_Suppl., S. 3587
    DOI (Open Access)
  • Stintzing, Sebastian; von Weikersthal, Ludwig; Fuchs, Martin; Kaiser, Florian; Heinrich, Kathrin; Modest, Dominik Paul; Hofheinz, Ralf; Decker, Thomas; Gerger, Armin; Angermeier, Stefan; Rumpold, Holger; Dickhut, Andreas; Öhler, Leopold; Gruenberger, Birgit; Niedersuess -Beke, Dora; Sandmann, Matthias; Winder, Thomas; Kasper, Stefan; Prager, Gerald; Heinemann, Volker
    Randomized study to investigate a switch maintenance concept with 5-FU plus bevacizumab after FOLFIRI plus cetuximab induction treatment versus continued treatment with FOLFIRI plus cetuximab : Report of a secondary endpoint of the phase-III FIRE-4 study (AIO KRK-0114)
    In: Journal of Clinical Oncology (JCO) , Jg. 40 2022, Nr. 16_Suppl., S. 3519
    DOI (Open Access)
  • Heinemann, V.; Fischer von Weikersthal, L.; Fuchs, M.; Kaiser, F.; Heinrich, K.; Modest, D.; Hofheinz, R.; Decker, T.; Gerger, A.; Angermeier, S.; Rumpold, H.; Dickhut, A.; Öhler, L.; Grünberger, B.; Niedersüß-Beke, D.; Sandmann, M.; Kasper, Stefan; Prager, G.; Stintzing, S.
    SO-16 FIRE-4 (AIO-KRK-0114) : Randomized study for a switch maintenance concept with 5-FU plus bevacizumab after induction treatment with FOLFIRI plus cetuximab versus continued treatment with FOLFIRI plus cetuximab – secondary endpoint
    ESMO 24th World Congress on Gastrointestinal Cancer 2022, 29 June -2 July 2022, Barcelona, Spain,
    In: Annals of Oncology , Jg. 33 2022, Nr. Suppl. 4, S. S363 – S364
    DOI (Open Access)
  • Pabst, K. M.; Trajkovic-Arsic, M.; Cheung, P. F.; Kessler, Lukas; Hirmas, N.; Nader, M.; Bartel, T.; Schaarschmidt, B. M.; Kasper, Stefan; Siveke, Jens T.; Hamacher, R.; Schmidt, H. H. J.; Ingenwerth, M.; Herrmann, Ken; Fendler, Wolfgang P.
    Superiority of [68Ga]Ga-FAPI-46 over [18F]F-FDG PET/CT for cholangiocarcinoma imaging
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022 Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 49 2022, Nr. Supplement 1, S. S192 – S193
    DOI (Open Access)
  • Hirmas, N.; Ingenwerth, M.; Sraieb, Miriam; Kessler, Lukas; Pabst, K. M.; Lanzafame, H.; Lückerath, Katharina; Kasper, Stefan; Nader, M.; Schildhaus, Hans-Ulrich; Hadaschik, Boris; Grünwald, Viktor; von Tresckow, Bastian; Hanoun, Christine; Aigner, Clemens; Glas, Martin; Herrmann, Ken; Siveke, Jens T.; Hamacher, R.; Fendler, Wolfgang P.
    Target Expression and FAP-Directed Tumour Imaging in a Large, Single-Centre PET Database of 324 Patients and 21 Tumour Entities
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 49 2022, Nr. Supplement 1, S. S119 – S120
    DOI (Open Access)
  • Klinghammer, K.; Graeven, U.; Ivanyi, P.; Dietz, A.; Hahn, D.; Hackenberg, S.; Kasper, Stefan; Fietkau, R.; Moulin, J.-C.; Pink, D.; Schaaf, M.; Grünwald, Viktor
    ELDORANDO : Pembrolizumab compared with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115)
    Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,
    In: Oncology Research and Treatment , Jg. 44 2021, Nr. Supplement 2, S. 56 – 57
    DOI (Open Access)
  • Modest, Dominik Paul; Karthaus, Meinolf; Frühauf, Stefan; Graeven, Ullrich; Müller, Lothar; Koenig, Alexander; Von Weikersthal, Ludwig Fischer; Caca, Karel; Kretzschmar, Albrecht; Goekkurt, Eray; Haas, Siegfried; Kurreck, Annika; Stahler, Arndt; Heinemann, Volker; Held, Swantje; Jarosch, Armin; Horst, David; Kasper, Stefan; Stintzing, Sebastian; Trarbach, Tanja
    Maintenance therapy with 5-fluoruracil/leucovorin (5FU/LV) plus panitumumab (pmab) or 5FU/LV alone in RAS wildtype (WT) metastatic colorectal cancer (mCRC) - the PANAMA trial (AIO KRK 0212)
    In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 15_Suppl, S. 3503 – 3503
    DOI (Open Access)
  • Saavedra Santa Gadea, O.; Greil, R.; de Jonge, M.J.A.; Tan, D.; Jerusalem, G.; Damian, S.; Grell, P.; Wainberg, Z.; Wolf, J.; Joerger, M.; Carlino, M.S.; Kasper, Stefan; Yap, T.A.; Otero, J.; Yang, X.; Nesbitt, V.; Kim, J.; Lee, L. Ho; Choudhury, S.; Leal, T.A.
    Phase (Ph) II study of taminadenant (NIR178) + spartalizumab (PDR001) in patients (pts) with microsatellite stable (MSS) colorectal cancer (CRC)
    In: Annals of Oncology , Jg. 32 2021, Nr. Suppl. 5, S. 552 – S553
    DOI (Open Access)
  • Seufferlein, Thomas; Ettrich, Thomas Jens; Stein, Alexander; Arnold, Dirk; Prager, Gerald W.; Kasper, Stefan; Niedermeier, Michael; Müller, Lothar; Kubicka, Stefan; Koenig, Alexander; Büchner-Steudel, Petra; Wille, Kai; Kestler, Angelika M. R.; Berger, Andreas W.; Perkhofer, Lukas; Lausser, Ludwig; Kestler, Hans A.
    Predicting resistance to first-line FOLFOX plus bevacizumab in metastatic colorectal cancer : Final results of the multicenter, international PERMAD trial
    2021 Gastrointestinal Cancers Symposium, 15-17 January 2021, online,
    In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 3, Supplement, S. 115 – 115
    DOI (Open Access)
  • Pöttgen, Christoph; Gkika, E.; Stahl, Michael; Abu Jawad, Jehad; Gauler, Thomas; Kasper, Stefan; Trarbach, Tanja; Herrmann, Ken; Lehmann, Nils; Jöckel, Karl-Heinz; Lax, H.; Stuschke, Martin
    Prognostic Significance of the metabolic Response during Induction Chemotherapy for the definitive Chemoradiotherapy of locally advanced Squamous Cell Carcinoma of the Esophagus
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 197 2021, Nr. Suppl. 1, S. 154 – S155
  • Kasper, Stefan; Goetze, Thorsten Oliver; Stintzing, Sebastian; Hofheinz, Ralf Dieter; Sinn, Marianne; Dechow, Tobias Nicolaas; Ettrich, Thomas Jens; Keitel, Verena; Graeven, Ullrich; Fischer von Weikersthal, Ludwig; Kolov, Alexander; Edelmann, Thomas; Stein, Alexander; Trarbach, Tanja; Junge, Sabine; Pauligk, Claudia; Virchow, Isabel; Siveke, Jens; Al-Batran, Salah-Eddin; Schuler, Martin
    RAMucirumab in combination with TAS102 versus TAS102 monotherapy in metastatic colorectal cancer : Safety results from the phase IIb part of the RAMTAS phase II/III trial of the German AIO (AIO-KRK-0316)
    In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 15_Suppl, S. 3566 – 3566
    DOI (Open Access)
  • Stintzing, Sebastian; Heinrich, Kathrin; Tougeron, David; Modest, Dominik Paul; Schwaner, Ingo; Euker, Jan; Pihusch, Rudolf; Stauch, Martina; Kaiser, Florian; Kahl, Christoph; Karthaus, Meinolf; Mueller, Christian; Burkart, Christof; Reinacher-Schick, Anke C.; Kasper, Stefan; Fischer von Weikersthal, Ludwig; Krammer-Steiner, Beate; Prager, Gerald W.; Taieb, Julien; Heinemann, Volker
    Randomized study to investigate FOLFOXIRI plus either bevacizumab or cetuximab as first-line treatment of BRAF V600E-mutant mCRC : The phase-II FIRE-4.5 study (AIO KRK-0116)
    In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 15_Suppl, S. 3502 – 3502
    DOI (Open Access)
  • Kasper, Stefan; Hofheinz, R.D.; Stintzing, S.; Götze, T.O.; Sinn, M.; Dechow, T.; Ettrich, T.J.; Keitel, V.; Graeven, U.; Fischer von Weikersthal, L.; Kolov, A.; Edelmann, T.; Stein, A.; Trarbach, T.; Junge, S.; Pauligk, C.; Virchow, I.; Siveke, Jens; Al-Batran, S-E.; Schuler, Martin
    Interim safety analysis of the phase IIb study of ramucirumab in combination with TAS102 vs. TAS102 monotherapy in metastatic colorectal cancer : The RAMTAS trial of the German AIO
    In: Annals of Oncology , Jg. 31 2020, Nr. Suppl. 4, S. S427 – S428
    DOI (Open Access)
  • Kraskowski, O.; Eberhardt, Wilfried; Metzenmacher, Martin; Zaun, Gregor; McCutcheon, A.; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Darwiche, Kaid; Aigner, Clemens; Kasper, Stefan; Hense, Jörg; Gruenwald, Viktor; Wiesweg, Marcel; Schuler, Martin; Pogorzelski, Michael
    Patients with metastatic EGFR-mutated non-small cell lung cancer (NSCLC) show highly favorable outcomes with treatment sequences provided at a comprehensive cancer center
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment , Jg. 43 2020, Nr. Suppl. 4, S. 137
    DOI (Open Access)
  • Kasper, Stefan; zur Hausen, Gerrit; Stein, Alexander; Stintzing, Sebastian; Berger, Andreas; Loges, Sonja; Hofheinz, Ralf; Trarbach, Tanja; Graeven, Ullrich; Fischer von Weikersthal, Ludwig; Goetze, Thorsten Oliver; Hagen, Volker A.; Burock, Susen; Hoffmeister, Albrecht; Dechow, Tobias Nicolaas; Pauligk, Claudia; Virchow, Isabel; Siveke, Jens; Al-Batran, Salah-Eddin; Schuler, Martin
    A phase IIb study of ramucirumab in combination with TAS102 versus TAS102 monotherapy in metastatic, chemotherapy refractory colorectal cancer patients : The RAMTAS trial of the German AIO (KRK-0316)
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. 15, S. TPS3617 – TPS3617
    DOI (Open Access)
  • Lorenzen, Sylvie; Quante, Michael; Rauscher, Isabel; Slotta-Huspenina, Julia; Becker, Karl Friedrich; Weichert, Wilko; Feith, Marcus; Friess, Helmut; Combs, Stephanie E.; Weber, Wolfgang; Haller, Bernhard; Angele, Martin K.; Albertsmeier, Markus; Blankenstein, Christiane; Kasper, Stefan; Zimmermann, Jens Peter; Algül, Hana; Schmid, Roland M.; Schwaiger, Markus; Siveke, Jens
    PET-directed combined modality therapy for gastroesophageal junction cancer : First results of the prospective MEMORI trial
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. 15, S. 4018 – 4018
    DOI (Open Access)
  • Kraemer, Alwin; Stein, Alexander; Huebner, Gerdt; Stahl, Michael; Kasper, Stefan; Kretzschmar, Albrecht; Kohne, Claus-Henning; Gruenwald, Viktor; Hofheinz, Ralf; Schuette, Katharina; Loeffler, Harald; Bokemeyer, Carsten; Folprecht, Gunnar
    Paclitaxel/carboplatin with or without cetuximab for treatment of carcinoma with unknown primary (PACET-CUP) : Results of a multi-center randomized phase II AIO trial
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. 15, S. 4120
    DOI (Open Access)
  • Meric-Bernstam, Funda; Sandhu, Shahneen Kaur; Hamid, Omid; Spreafico, Anna; Kasper, Stefan; Dummer, Reinhard; Shimizu, Toshio; Steeghs, Neeltje; Lewis, Nancy; Talluto, Craig C.; Dolan, Sinead; Bean, Andrew; Brown, Robert; Trujillo, Damian; Nair, Nitya; Luke, Jason J.
    Phase Ib study of MIW815 (ADU-S100) in combination with spartalizumab (PDR001) in patients (pts) with advanced/metastatic solid tumors or lymphomas
    In: Journal of Clinical Oncology (JCO) , Jg. 37 2019, Nr. 15, S. 2507 – 2507
    DOI (Open Access)
  • Seufferlein, Thomas; Lausser, Ludwig; Stein, Alexander; Prager, Gerald W.; Kasper, Stefan; Niedermeier, Michael; Müller, Lothar; Kubicka, Stefan; Koenig, Alexander; Buechner-Steudel, Petra; Wille, Kai; Perkhofer, Lukas; Hann, Alexander; Berger, Andreas Wolfgang; Arnold, Dirk; Kestler, Hans; Ettrich, Thomas Jens
    A novel biomarker combination and its association with resistance to chemotherapy combinations with bevacizumab : First results of the PERMAD trial
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. Suppl. 15, S. e15545 – e15545
    DOI (Open Access)
  • Cao, J.; Wiesweg, Marcel; Fuchs, M.; Stein, A.; Karthaus, M.; Lettmaier, S.; Kretzschmar, A.; Draube, A.; Ettrich, T.; Rüssel, J.; Müller, C.; Rafiyan, M.-R.; Borchert, K.; Schuler, Martin; Kasper, Stefan
    Efficacy and safety of Trifluridin/Tipiracil (FTD/TPI) (Lonsurf (R)) in patients with metastatic colorectal cancer (CRC) in clinical-routine use
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment , Jg. 41 2018, Nr. Suppl. 4, S. 289
    DOI (Open Access)
  • Slaski, C.; Kasper, Stefan; Paul, Andreas; Gerken, G.; Schmid, Kurt Werner; Meiler, Johannes; Teckelnborg, K.; Dechene, Alexander; Schumacher, B.; Markus, P.; Schuler, Martin; Virchow, I.
    Evaluation of prognostic markers in patients (pts) with advanced gastric cancer (GC) and adenocarcinoma of the gastroesophageal junction (AEG) treated with systemic chemothearpy (ctx) at the West German Cancer Center
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment , Jg. 41 2018, Nr. Suppl. 1, S. 67
    DOI (Open Access)
  • Kasper, Stefan; Gillison, M. L.; Blumenschein, G.; Fayette, J.; Guigay, J.; Colevas, A. D.; Licitra, L.; Harrington, K.; Vokes, Everett E.; Even, C.; Worden, F.; Saba, N. F.; Docampo, L. C. I.; Haddad, R.; Rordorf, T.; Kiyota, N.; Makoto, T.; Lynch, M.; Kopit, J.; Ferris, R. L.
    Nivolumab (Nivo) vs Investigator‘s Choice (IC) for Platinum-Refractory (PR) Recrrent or Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN; CheckMate 141) : Outcomes in First-line (1L) R/M Patients (Pts) and Updated Safety and Efficacy
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment , Jg. 41 2018, Nr. Suppl. 1, S. 96
    DOI (Open Access)
  • Ferris, Robert L.; Blumenschein, George R.; Fayette, Jerome; Guigay, Joel; Colevas, A Dimitrios; Licitra, Lisa; Harrington, Kevin J.; Kasper, Stefan; Vokes, Everett E.; Even, Caroline; Worden, Francis; Saba, Nabil F.; Docampo, Lara Carmen Iglesias; Haddad, Robert; Rordorf, Tamara; Kiyota, Naomi; Tahara, Makoto; Lynch, Mark; Jayaprakash, Vijayvel; Li, Li; Gillison, Maura L.
    Nivolumab (Nivo) vs investigator's choice (IC) in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) : 2-yr outcomes in the overall population and PD-L1 subgroups of CheckMate 141
    In: Cancer Research , Jg. 78 2018, Nr. Suppl. 13
    DOI (Open Access)
  • Waberer, Lisa; Homann, Nils; Wirtz, Ralph M.; Schmalenberg, Harald; Haag, Georg Martin; Schuler, Martin; Kasper, Stefan; Goetze, Thorsten Oliver; Pauligk, Claudia; Hofheinz, Ralf; Al-Batran, Salah-Eddin
    PD-L1 mRNA expression in patients with resectable gastric cancer and adenocarcinoma of the oesophago-gastric junction undergoing perioperative chemotherapy : Results from the FLOT4 phase III trial of the AIO
    In: Journal of Clinical Oncology (JCO) , Jg. 36 2018, Nr. Suppl. 15, S. e24277 – e24277
    DOI (Open Access)
  • Wiesweg, Marcel; Reis, Henning; Köster, T.; Goetz, M.; Worm, K.; Herold, T.; Paul, Andreas; Dechene, Alexander; Schumacher, B.; Markus, P.; Virchow, I.; Kostbade, K.; Wolf, N.; Zaun, G.; Metzenmacher, M.; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Signaling network activation in colorectal cancer : p70S6K phosphorylation as a prognostic marker
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment , Jg. 41 2018, Nr. Suppl. 1, S. 55
    DOI (Open Access)
  • Stein, G.; Stelmach, Patrick; Kasper, Stefan; Paul, Andreas; Wedemeyer, Heiner H.; Schmid, Kurt Werner; Schumacher, B.; Markus, P.; Siffert, Winfried; Schuler, Martin; Bachmann, Hagen Sjard; Virchow, I.
    The prognostic impact of UDP-glucuronyltransferase 1A1*1 (UGT1A1*1) polymorphism in patients with advanced colorectal and non-colorectal cancer treated with irinotecan-based systemic chemotherapies
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment , Jg. 41 2018, Nr. Suppl. 4, S. 122 – 123
    DOI (Open Access)
  • Ferris, R. L.; Blumenschein, G. R.; Fayette, J.; Guigay, J.; Colevas, A. D.; Licitra, L.; Harrington, K.; Kasper, Stefan; Vokes, E. E.; Even, C.; Worden, F.; Saba, N. F.; Docampo, L.; Haddad, R. I.; Rordorf, T.; Kiyota, N.; Tahara, M.; Lynch, M.; Li, L.; Gillison, M.
    Two-year Update From CheckMate 141 : Outcomes With Nivolumab (Nivo) vs Investigator's Choice (IC) in Recurrent or Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN) in the Overall Population and PD-L1 Subgroups
    2018 Multidisciplinary Head and Neck Cancers Symposium ; Expanding Treatment Horizons ; February 15-17, 2018, Scottsdale, Arizona, USA,
    In: International Journal of Radiation Oncology, Biology, Physics , Jg. 100 2018, Nr. 5, S. 1317 – 1317
    DOI (Open Access)
  • Licitra, L.; Ferris, R. L.; Blumenschein, G.; Harrington, K. J.; Guigay, J.; Kasper, Stefan; Saba, N. F.; Haddad, R.; Kiyota, N.; Monga, M.; Lynch, M.; Li, L.; Gillison, M. L.; Fayette, J.
    Nivolumab vs investigator's choice (IC) in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) : treatment effect on clinical outcomes by best overall response in checkmate 141
    42nd ESMO Congress (ESMO 2017) ; 8-12 September 2017, Madrid, Spain,
    In: Annals of Oncology , Jg. 28 2017, Nr. Suppl. 5, S. v377 – v378
    DOI
  • Haddad, R.; Blumenschein, G.; Fayette, J.; Guigay, J.; Colevas, A. D.; Licitra, L.; Kasper, Stefan; Vokes, Everett E.; Worden, F.; Saba, N. F.; Tahara, M.; Concha-Benavente, F.; Monga, M.; Lynch, M.; Li, L.; Shaw, J. W.; Gillison, M. L.; Harrington, K. J.; Ferris, R. L.
    Treatment beyond progression with nivolumab in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) in the phase 3 checkmate 141 study : A biomarker analysis and updated clinical outcomes
    42nd ESMO Congress (ESMO 2017) ; 8-12 September 2017, Madrid, Spain,
    In: Annals of Oncology , Jg. 28 2017, Nr. Suppl. 5, S. v372 – v373
    DOI
  • Lückerath, M.; Kasper, Stefan; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Meiler, Johannes; Wiesweg, M.; Neuhaus, I.; Dechene, Alexander; Mende, B.; Schumacher, B.; Markus, P.; Schuler, Martin; Virchow, I.
    Evaluation of prognostic markers in patients (pts) with metastatic colorectal cancer (mCRC) treated with a bevacizumab (bev) based chemotherapy (ctx) at the West German Cancer Center
    Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,
    In: Oncology Research and Treatment , Jg. 39 2016, Nr. Suppl. 1, S. 77
    DOI
  • Pogorzelski, M.; Hilser, T.; Ting, Saskia; Vossebein, I.; Gauler, Thomas; Abendroth, A.; Lang, Stephan; Stuck, Boris; Abu-Jawad, J.; Stuschke, Martin; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Evaluation of systemic inflammatory response (SIR) markers in recurrent or metastatic head and neck squamous cell carcinoma (r/m HNSCC)
    In: Oncology Research and Treatment , Jg. 39 2016, Nr. Suppl. 3, S. 307 – 308
    DOI
  • Abendroth, A.; Markus, M.; Abramczyk, M.; Noureddine, R.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Schumacher, B.; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Trarbach, Tanja; Schuler, Martin; Kasper, Stefan
    Evaluation of systemic inflammatory response (SIR) markers in advanced biliary tract cancer (ABTC)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,
    In: Oncology Research and Treatment , Jg. 38 2015, Nr. Suppl. 5, S. 5 – 6
    DOI
  • Markus, M.; Kasper, Stefan; Noureddine, R.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Schumacher, B.; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Trarbach, Tanja; Schuler, Martin; Abendroth, A.
    Evaluation of systemic inflammatory response (SIR) markers in pancreatic ductal adenocarcinoma (PDAC)
    In: Oncology Research and Treatment , Jg. 38 2015, Nr. S 5, Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz, S. 4 – 5
    DOI
  • Abendroth, A.; Noureddine, R.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Meiler, Johannes; Wiesweg, M.; Dechene, Alexander; Schumacher, B.; Kaiser, Gernot Maximil; Schuler, Martin; Kasper, Stefan
    Prognostische Faktoren bei Patienten mit fortgeschrittenen Pankreaskarzinomen, die am Westdeutschen Tumorzentrum (WTZ) sequentielle Chemotherapien erhalten haben
    121. Kongress der Deutschen Gesellschaft für Innere Medizin ; DGIM 2015 ; 18. - 21. April 2015, Mannheim, Germany,
    In: Der Internist , Jg. 56 2015, Nr. Supplement 1: Abstracts zum 121. Kongress der Deutschen Gesellschaft für Innere Medizin e.V., S. 38 – 39
    DOI
  • Abendroth, A.; Abramczyk, M.; Noureddine, R.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Baba, Hideo Andreas; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Bockisch, Andreas; Dechene, Alexander; Forsting, Michael; Schuler, Martin; Kasper, Stefan
    Prognostische Faktoren bei Patienten mit fortgeschrittenen cholangiozellulären Karzinomen, die am Westdeutschen Tumorzentrum (WTZ) sequentielle Chemotherapien erhalten haben
    121. Kongress der Deutschen Gesellschaft für Innere Medizin ; DGIM 2015 ; 18. - 21. April 2015, Mannheim, Germany,
    In: Der Internist , Jg. 56 2015, Nr. Supplement 1: Abstracts zum 121. Kongress der Deutschen Gesellschaft für Innere Medizin e.V., S. 37
    DOI
  • Kasper, Stefan; Möhler, Markus; Hegewisch-Becker, Susanna; Overkamp, Friedrich; Bechstein, Wolf O.; Kullmann, Frank; Lang, Hauke; Schön, Michael; Smith-Machnow, Victoria; Seehofer, Daniel; Vöhringer, Matthias; Geissler, Michael; Greil, Richard; Heike, Michael; Heinemann, Volker; Lordick, Florian; Galle, Peter R.; Schimanski, Carl Christoph
    A randomized, double-blind, placebo-controlled, multicenter, binational, phase II trial of immunotherapy with L-BLP25 (tecemotide) in patients with colorectal carcinoma following R0/R1 hepatic metastasectomy
    In: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 15, suppl., S. TPS3658
    DOI
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Hohler, T.; Reimer, P.; Steinmetz, T.; Berger, W.; Linden, G.; Ting, Saskia; Markus, P.; Paul, Andreas; Dechene, Alexander; Kostbade, K.; Schuler, Martin; Trarbach, Tanja
    Cetuximab biweekly plus mFOLFOX6 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC) - Primary endpoint analysis of the CEBIFOX trial
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl. 5, S. 99 – 100
    DOI
  • Köhler, Jens; Schuler, Martin; Gauler, Thomas; Nopel-Dunnebacke, S.; Hoffmann, Andreas-Claudius; Kasper, Stefan; Nensa, Felix; Gomez, Benedikt; Hahnemann, M.; Breitenbücher, Frank; Cheufou, D.; Ozkan, F.; Darwiche, Kaid; Hoiczyk, M.; Welter, Stefan; Eberhardt, Wilfried; Teschler, Helmut; Stamatis, Georgios; Hahn, S. A.; Baraniskin, A.
    Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl. 5, S. 226 – 227
    DOI
  • Gauler, Thomas; Pogorzelski, M.; Ting, Saskia; Breitenbücher, Frank; Vossebein, I.; Hoffarth, S.; Lang, Stephan; Bergmann, Christoph; Abu Jawad, Jehad; Markowetz, J.; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Impact of human papilloma virus infection on the response of head and neck cancers (HNSCC) to anti-epidermal growth factor receptor (EGFR) antibody therapy
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl. 1, S. 76
    DOI
  • Kasper, Stefan; Ting, Saskia; Meiler, Johannes; Knipp, Heike; Hohler, T.; Reimer, P.; Steinmetz, T.; Berger, W.; Linden, G.; Worm, K.; Schmid, Kurt Werner; Markus, P.; Paul, Andreas; Dechene, Alexander; Forsting, Michael; Kostbade, K.; Trarbach, Tanja; Schuler, Martin
    Molecular and clinical predictors of the efficacy of cetuximab in combination with mFOLFOX6 in 1st line treatment of patients (pts) with metastatic colorectal cancer (mCRC) : subgroup analyses of the CEBIFOX trial
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl. 5, S. 100 – 101
    DOI
  • Kasper, Stefan; Abendroth, A.; Abramczyk, M.; Noureddine, R.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Schuler, Martin
    Outcome of patients (pts) with advanced pancreaticobiliary cancers treated with sequential chemotherapies at the West German Cancer Center (WTZ)
    Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl. 1, S. 51
    DOI
  • Welt, Anja; Kasper, Stefan; Tewes, Mitra; Aktas, B.; Hoffmann, Oliver; Wiesweg, M.; Ting, Saskia; Reis, Henning; Worm, K.; Richly, Heike; Hense, Jörg; Palmer, M. R.; Lee, B. H.; Wendling, J.; Kossow, J.; Scheulen, Max Ernst; Lehnerdt, C.; Kohl, M.; Derks, C.; Slottky, S.; Haus, U.; Schmid, Kurt Werner; Kimmig, Rainer; Schuler, Martin
    Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients
    In: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl. 1: 31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie Berlin, 19.-22. Februar 2014: Abstracts, S. 19
    DOI (Open Access)
  • Abendroth, A.; Abramczyk, M.; Nourredine, R.; Paul, A.; Gerken, Guido; Schmid, Kurt Werner; Baba, Hideo Andreas; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Bockisch, Andreas; Forsting, Michael; Schuler, Martin; Kasper, Stefan
    Prognostic factors in patients (pts) with advanced cholangiocellular carcinoma (CCC) receiving sequential chemotherapies (CTX) at the West German Cancer Center (WTZ)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl. 5, S. 122 – 123
    DOI
  • Abendroth, A.; Nourredine, R.; Abramczyk, M.; Paul, A.; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Schuler, Martin; Kasper, Stefan
    Prognostic factors in patients with pancreatic cancer receiving sequential chemotherapies (CTX) at the West German Cancer Center (WTZ), one of the 12 Oncology Centers of Excellence in Germany
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl. 5, S. 123 – 124
    DOI
  • Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, K.; Kasper, Stefan; Bauer, Sebastian; Gauler, Thomas; Welt, Anja; Richly, Heike; Tewes, Mitra; Meiler, Johannes; Hense, Jörg; Eberhardt, Wilfried; Derks, Christian; Cortes-Incio, D.; Skottky, S.; Wohlschläger, Jeremias; Breitenbucher, F.; Freitag, Lutz; Stamatis, Georgios; Schmid, Kurt Werner; Schuler, Martin
    WTZ-Tumorprofil-A preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center : Two years experience
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin, Germany,
    In: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl. 1, S. 2 – 3
    DOI
  • Kasper, Stefan; Breitenbücher, Frank; Markowetz, J.; Reis, Henning; Ting, Saskia; Worm, K.; Meiler, Johannes; Schmid, Kurt Werner; Trarbach, Tanja; Schuler, Martin
    Molecular dissection of effector mechanisms of RAS-induced resistance to monoclonal anti-EGFR antibodies
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie , Jg. 36 2013, Nr. Suppl. 7, S. 116 – 117
    DOI
  • Abendroth, A.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Meiler, Johannes; Tometten, M.; Wiesweg, Marcel; Kaiser, Gernot Maximil; Dechene, Alexander; Trarbach, Tanja; Schuler, Martin; Kasper, Stefan
    Outcome of patients (pts) with advanced pancreaticobiliary cancers treated with sequential chemotherapies at the West German Cancer Center (WTZ), one of the 11 Oncology Centers of Excellence in Germany
    17 Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie , Jg. 36 2013, Nr. Suppl. 7, S. 263
    DOI
  • Tewes, Mitra; Kasper, Stefan; Aktas, B.; Hoffmann, A.; Wiesweg, M.; Ting, Saskia; Reis, Henning; Worm, K.; Richly, Heike; Hense, Jörg; Kern, P.; Scheulen, Max Ernst; Skottky, S.; Peters, M.; Schlegel, R.; Lee, B. H.; Palmer, M. R.; Monahan, J. E.; Haus, U.; Schmid, Kurt Werner; Kimmig, Rainer; Schuler, Martin; Welt, Anja
    Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastastic breast cancer patients
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Oncology Research and Treatment , Jg. 36 2013, Nr. Suppl. 7, S. 157
    DOI
  • Even, A.; Kasper, Stefan; Breitenbucher, F.; Pogorzelski, M.; Hoffarth, S.; Trarbach, Tanja; Schuler, Martin
    Targeting NF-kappa B and PLK-1 to overcome RAS-mediated resistance to anti-EGFR antibody therapy in colorectal cancer
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie , Jg. 33 2010, Nr. Suppl. 6, S. 33
    DOI

    • Bücher/Sammelwerke/Tagungsbände

  • Kasper, Stefan
    Therapeutische Modulation onkogener Signaltransduktion bei malignen Erkrankungen und Mechanismen der Resistenzentwicklung
    Duisburg, Essen 2014

    • Poster / Posterbeiträge

  • Pabst, Kim M.; Bartel, Timo; Sandach, Patrick; Laschinsky, Christina; Weber, Manuel M.; Kessler, Lukas; Küper, Alina T.; Hadaschik, Boris A.; Kesch, Claudia; Hamacher, Rainer; Kasper, Stefan; Podleska, Lars E.; Siveke, Jens T.; Eckstein, Markus; von Tresckow, Bastian; Kuemmel, Sherko; Reinacher-Schick, Anke; Uhl, Waldemar; Herrmann, Ken; Fendler, Wolfgang P.
    68Ga-FAPI-46 PET/CT for cancer imaging : Results of a single-center, prospective, interventional, single-arm clinical trial
    2025 ASCO Genitourinary Cancers Symposium, February 13-15, 2025, San Francisco, CA, USA,
    In: Journal of Clinical Oncology (JCO) , Jg. 43 2025, Nr. 5, Supplement, 457
    DOI
  • Stahler, Arndt; Hoppe, Beeke; Keilholz, Luisa; Na, Il-Kang; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Fischer Von Weikersthal, Ludwig; Kasper, Stefan; Ballhausen, Alexej; Sommerhäuser, Greta; Alig, Annabel Helga Sophie; Kurreck, Annika; Held, Swantje; Heinemann, Volker; Horst, David; Jarosch, Armin; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik Paul
    Combined amphiregulin and epiregulin expression as a prognostic and predictive biomarker of panitumumab (Pmab), fluorouracil, and folinic acid (FU/FA) or FU/FA maintenance therapy following Pmab+FOLFOX induction in RAS wildtype metastatic colorectal cancer (mCRC) : PANAMA trial (AIO-KRK-0212)
    2024 ASCO Annual Meeting, May 31 - June 4, 2024, Online und Chicago, IL, USA,
    In: Journal of Clinical Oncology (JCO) , Jg. 42 2024, Nr. Suppl. 16, 3528
    DOI
  • Pogorzelski, Michael; Klinghammer, K.; Hilser, Thomas; Kasper, Stefan; Grünwald, Viktor; et al.
    Analysis of ecacy and treatment pattern of second-line therapy after failure of immunotherapy-based treatment in recurrent or metastatic head and neck squamous cell carcinoma (r/m SCCHN) using the head and neck clinical research platform (HEAT)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment , Jg. 46 2023, Nr. Supplement 5: DGHO Abstracts, S. 244
    DOI (Open Access)
  • Pogorzelski, M.; Lauri, F.; Hilser, T.; Hense, Jörg; Ting, Saskia; Kansy, B.; Gauler, Thomas; Stuschke, Martin; Schmid, Kurt Werner; Lang, Stephan; Zaun, G.; Grünwald, Viktor; Schuler, Martin; Kasper, Stefan
    Efficacy of immunotherapy (IO) and subsequent systemic treatment after failure of IO in patients with recurrent or metastatic head and neck cancer in a real-world setting
    ESMO Congress 2021, 16 – 21 September 2021, Virtual,
    In: Annals of Oncology , Jg. 32 2021, Nr. Suppl. 5, S. S812
    DOI (Open Access)
  • Grünwald, Viktor; Graeven, U.; Ivanyi, P.; Dietz, A.; Hahn, D.; Hackenberg, S.; Kasper, Stefan; Fietkau, R.; Moulin, J-C.; Pink, D.; Schaaf, M.; Klinghammer, K.
    Results of a randomized phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115)
    ESMO Congress 2021, 16 – 21 September 2021, Virtual,
    In: Annals of Oncology , Jg. 32 2021, Nr. Suppl. 5, S. S807 – S808
    DOI (Open Access)
  • Köhler, Jens; Schuler, Martin; Kasper, Stefan; Nensa, Felix; Hense, Jörg; Forsting, Michael; Kühl, Hilmar
    Formation of multiple pneumatoceles during anti-angiogenic treatment for metastatic colorectal cancer
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.–14. Oktober 2014, Hamburg, Germany,
    In: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl. 5, S. 84 – 85
    DOI
  • Breitenbücher, Frank; Hoffarth, S.; Gauler, Thomas; Stergar, S. L.; Kasper, Stefan; Köhler, Jens; Worm, K.; Marten, A.; Schmid, Kurt Werner; Schuler, Martin
    Highly sensitive detection of somatic epidermal growth factor receptor (EGFR) gene mutations in circulating tumor cells (CTC) from patients with non-small cell lung cancer treated with cisplatin/pemetrexed or afatinib
    14th World Conference on Lung Cancer, July 3 – 7, 2011, Amsterdam, The Netherlands,
    In: Journal of Thoracic Oncology , Jg. 6 2011, Nr. 6, Suppl. 2, S. S956 – S957
    DOI